Document:

EX-10.9

 EXHIBIT 10.9 
  

 
 REGISTRATION RIGHTS AGREEMENT

 BY AND AMONG 

ENSEMBLE HEALTH PARTNERS, INC. 

AND 
 THE STOCKHOLDERS
PARTY HERETO 
 DATED AS OF [    ], 2021 

 
  
  

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
	
	ARTICLE I	  

	
	EFFECTIVENESS	  

			
	 Section 1.1
	  	Effectiveness	  	 	1	 
	
	ARTICLE II	  

	
	DEFINITIONS	  

			
	 Section 2.1
	  	Definitions	  	 	2	 
	 Section 2.2
	  	Other Terms	  	 	5	 
	 Section 2.3
	  	Other Interpretive Provisions	  	 	6	 
	
	ARTICLE III	  

	
	REGISTRATION RIGHTS	  

			
	 Section 3.1
	  	Demand Registration	  	 	7	 
	 Section 3.2
	  	Shelf Registration	  	 	10	 
	 Section 3.3
	  	Piggyback Registration	  	 	13	 
	 Section 3.4
	  	Lock-Up Agreements	  	 	14	 
	 Section 3.5
	  	Registration Procedures	  	 	15	 
	 Section 3.6
	  	Underwritten Offerings	  	 	20	 
	 Section 3.7
	  	No Inconsistent Agreements; Additional Rights	  	 	21	 
	 Section 3.8
	  	Registration Expenses	  	 	22	 
	 Section 3.9
	  	Indemnification	  	 	22	 
	 Section 3.10
	  	Rules 144 and 144A and Regulation S	  	 	25	 
	 Section 3.11
	  	Existing Registration Statements	  	 	26	 
	
	ARTICLE IV	  

	
	MISCELLANEOUS	  

			
	 Section 4.1
	  	Authority; Effect	  	 	26	 
	 Section 4.2
	  	Notices	  	 	26	 
	 Section 4.3
	  	Termination and Effect of Termination	  	 	28	 
	 Section 4.4
	  	Permitted Transferees	  	 	28	 
	 Section 4.5
	  	Remedies	  	 	28	 
	 Section 4.6
	  	Amendments	  	 	28	 
	 Section 4.7
	  	Governing Law	  	 	28	 
	 Section 4.8
	  	Consent to Jurisdiction	  	 	29	 
	 Section 4.9
	  	WAIVER OF JURY TRIAL	  	 	29	 
	 Section 4.10
	  	Merger; Binding Effect, Etc.	  	 	30	 

  
 i 

							
	 Section 4.11
	 	Counterparts; Electronic Signatures	  	 	30	 
	 Section 4.12
	 	Severability	  	 	30	 
	 Section 4.13
	 	No Recourse	  	 	30	 

  

  
 ii 

 This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in
accordance with the terms hereof, the “Agreement”), dated as of [ ], 2021 is made by and among Ensemble Health Partners, Inc., a Delaware corporation (the “Company”), EHL Acquisition Holdings, LLC, a Delaware
limited liability company (the “GGC”); Bon Secours Mercy Health Innovations, LLC, an Ohio limited liability company (“Innovations”) and such other Persons, if any, that from time to time become party hereto as
holders of Registrable Securities pursuant to Section 4.4 in their capacity as Permitted Transferees. 
 W I T N E
S S E T H: 
 WHEREAS, on the date hereof, the Company has priced an initial public offering (the “IPO”) of shares of its
Class A common stock, par value $0.001 per share (the “Class A Common Stock”), pursuant to an underwriting agreement dated as of the date hereof; 

WHEREAS, in connection with the IPO (a) the amended and restated limited liability company agreement (the “Operating
Agreement”) of Ensemble Health Partners Holdings, LLC, a Delaware limited liability company (“Ensemble”) will be amended and restated, with the Company becoming Ensemble’s sole managing member and (b) pursuant to
a series of exchanges and contributions, the Company will issue shares of Class A Common Stock and shares of Class B common stock, par value $0.001 per share (the “Class B Common Stock” and, together
with the Class A Common Stock, the “Common Stock”), to the Holders (as herein defined); 
 WHEREAS, after the
completion of the IPO, the Common Units of Ensemble (the “LLC Units”), together with shares of Class B Common Stock will, subject to certain restrictions, be redeemable from time to time at the option of the Holder thereof for
shares of Class A Common Stock, pursuant to the Operating Agreement; and 
 WHEREAS, the parties believe that it is in the best
interests of the Company and the other parties hereto to set forth their agreements regarding registration rights and certain other matters following the closing of the IPO. 

NOW, THEREFORE, in consideration of the foregoing and the mutual promises, covenants and agreements of the parties hereto, and for other good
and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: 
 ARTICLE I

 EFFECTIVENESS 

Section 1.1 Effectiveness. This Agreement shall become effective upon the execution of the underwriting agreement in respect of
the IPO. 

 ARTICLE II 

DEFINITIONS 
 Section 2.1
Definitions. As used in this Agreement, the following terms shall have the following meanings: 
 “Adverse
Disclosure” means public disclosure of material non-public information that, in the good faith judgment of the Board of Directors of the Company after consultation with outside counsel: (i) would
be required to be made in any Registration Statement filed with the SEC by the Company so that such Registration Statement, from and after its effective date, does not contain an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein not misleading; (ii) would not be required to be made at such time but for the filing, effectiveness or continued use of such Registration Statement; and (iii) the
Company has a bona fide business purpose for not disclosing publicly. 
 “Affiliate” means, with respect to any specified
Person, (a) any Person that directly or indirectly through one or more intermediaries controls or is controlled by or is under common control with such specified Person; provided that the Company and each Subsidiary of the Company shall
be deemed not to be an Affiliate of any of the GGC Investor or the BSMH Investor. “Affiliated” and “Affiliation” shall have correlative meanings. As used in this definition, the term “control” means the
possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through ownership of voting securities, by contract or otherwise. 

“Block Trade Offering” means any bought deal or block sale to a financial institution conducted as an underwritten Public
Offering. 
 “Business Day” means any day other than a Saturday or Sunday or any other day on which commercial banks are
required or permitted to close by law in the City of New York, New York. 
 “BSMH” means Bon Secours Mercy Health, Inc., a
Maryland nonprofit corporation that is a Code Section 501(c)(3) charitable organization and is a public charity within the meaning of Code Section 509(a)(1). 

“BSMH Investor” means Innovations, together with its Permitted Transferees that hold Registrable Securities. 

“Closing” shall mean the closing of the IPO. 

“Coordination Agreement” means that certain Coordination Agreement, dated on or about the date hereof, by and among the BSMH
Investor and the GGC Investor. 
 “Demanding Holder” means any of the GGC Investor or the BSMH Investor that exercises a
right to request a Demand Registration pursuant to Section 3.1. 
 “Effective Date” means the date of
the Closing. 
 “Exchange Act” means the Securities Exchange Act of 1934. 

  
 2 

 “Excluded Registration” means (i) a registration relating to the sale
of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan on Form S-8 or its successor approved by the Board of Directors of the Company or
(ii) a registration statement on Form S-4 or its successor. 
 “FINRA” means
the Financial Industry Regulatory Authority. 
 “GGC” shall have the meaning set forth in the Preamble. 

“GGC Investor” means, collectively, GGC, together with its Permitted Transferees that hold Registrable Securities. 

“Holder” means any Principal Stockholder for so long as it holds Registrable Securities. 

“IPO” shall have the meaning set forth in the Recitals. 

“Issuer Free Writing Prospectus” means an issuer free writing prospectus, as defined in Rule 433 under the Securities Act,
relating to an offer of the Registrable Securities. 
 “Issuer Shares” means the shares of Common Stock or other equity
securities of the Company, and any securities into which such shares of Common Stock or other equity securities shall have been converted or exchanged or any securities resulting from any reclassification or recapitalization of such shares of Common
Stock or other equity securities. 
 “LLC Units” shall have the meaning set forth in the Recitals. 

“Permitted Transferee” means with respect to any Holder, any Affiliate of such Holder. 

“Person” means any individual, partnership, corporation, company, association, trust, joint venture, limited liability
company, unincorporated organization, entity or division, or any government, governmental department or agency or political subdivision thereof. 

“Pre-Approved Transfer” means a Transfer by the BSMH Investor to an Affiliate that
(i) does not involve a disposition for value and (ii) in respect of which the Transferee has duly and validly executed and delivered an agreement to be bound by the provisions of Section 3.4 of this Agreement to
the same extent as if it were the BSMH Investor, in form and substance reasonably satisfactory to the Company. 
 “Principal
Stockholder” means each of the BSMH Investor and the GGC Investor. 
 “Pro Rata Portion” means, with respect to
each Holder requesting that its shares be registered or sold in a Public Offering, a number of such shares equal to the aggregate number of Registrable Securities requested to be registered or sold in such Public Offering (excluding any shares to be
registered or sold for the account of the Company) multiplied by a fraction, the numerator of which is the aggregate number of Registrable Securities held by such Holder immediately following Closing (after giving effect to any exercise by the
underwriters of their option to purchase additional shares as well as the repurchase of Class B Common Stock and LLC Units by the Company, if any, in connection with the closing of the IPO), and the denominator of which is the aggregate number
of Registrable Securities held by all Holders immediately following Closing (after giving effect to any exercise by the underwriters of their option to purchase additional shares as well as the repurchase of Class B Common Stock and LLC Units
by the Company, if any, in connection with the closing of the IPO). 

  
 3 

 “Prospectus” means (i) the prospectus included in any Registration
Statement, all amendments and supplements to such prospectus, including post-effective amendments and supplements, and all other material incorporated by reference in such prospectus, and (ii) any Issuer Free Writing Prospectus. 

“Public Offering” means the offer and sale of Registrable Securities for cash pursuant to an effective Registration Statement
under the Securities Act (other than a Registration Statement on Form S-4 or Form S-8 or any successor form). 

“Redemption” means a redemption of Class B Common Stock (together with LLC Units) for Class A Common Stock effected
in accordance with Section 9.01 of the Operating Agreement. 
 “Registrable Securities” means (i) all shares of
Class A Common Stock, and any securities into which such Class A Common Stock shall have been converted or exchanged, that are not then subject to vesting or forfeiture to the Company, (ii) all shares of Class A Common Stock
issuable upon exercise, conversion or exchange of any option, warrant or convertible or other security not then subject to vesting or forfeiture to the Company (including shares of Class A Common Stock issuable upon a Redemption), (iii) all
shares of Class A Common Stock issuable in a Redemption and (iv) all shares of Class A Common Stock directly or indirectly issued or issuable with respect to the securities referred to in clauses (i), (ii) or (iii) above by way
of unit or stock dividend or unit or stock split, or in connection with a combination of units or shares, reclassification, recapitalization, merger, consolidation or other reorganization. As to any particular Registrable Securities, such securities
shall cease to be Registrable Securities when (w) a Registration Statement with respect to the sale of such securities shall have been declared effective under the Securities Act and such securities shall have been disposed of in accordance
with such Registration Statement, (x) such securities shall have been Transferred pursuant to Rule 144, (y) the holder is able to immediately sell such securities (including all shares of Class A Common Stock issuable upon a
Redemption) under Rule 144 without any restrictions on transfer (including without application of paragraphs (c), (d), (e), (f) and (h) of Rule 144), as determined in the reasonable judgment of the holder (it being understood that a written
opinion of the Company’s outside legal counsel to the effect that such securities may be so sold shall be conclusive evidence this clause has been satisfied), or (z) such securities shall have ceased to be outstanding. 

“Registration” means registration under the Securities Act of the offer and sale to the public of any Issuer Shares under a
Registration Statement. The terms “register,” “registered” and “registering” shall have correlative meanings. 

“Registration Statement” means any registration statement of the Company filed with, or to be filed with, the SEC under the
Securities Act, including the related Prospectus, amendments and supplements to such registration statement, including pre- and post-effective amendments, and all exhibits and all material incorporated by
reference in such registration statement other than a registration statement (and related Prospectus) filed on Form S-4 or Form S-8 or any successor form thereto. 

  
 4 

 “Representatives” means, with respect to any Person, any of such
Person’s officers, directors, employees, agents, attorneys, accountants, actuaries, consultants, equity financing partners or financial advisors or other Person associated with, or acting on behalf of, such Person. 

“Requisite Investor Approval” means the approval of (a) each of the Principal Stockholders that then holds Registrable
Securities and (b) to the extent only one Principal Stockholder holds Registrable Securities, such Principal Stockholder; provided that, for purposes of this definition, a Principal Stockholder shall be deemed to have approved an action
to the extent that such Principal Stockholder or its Affiliates holding a majority of the Issuer Shares held by such Principal Stockholder and its Affiliates in the aggregate vote in favor of, or provide their written consent to, such action. 

“Rule 144” means Rule 144 under the Securities Act (or any successor rule). 

“SEC” means the Securities and Exchange Commission or any successor agency having jurisdiction under the Securities Act. 

“Securities Act” means the Securities Act of 1933. 

“Stockholders Agreement” means the Stockholders Agreement, dated on or about the date hereof, made by and among the Company,
GGC, BSMH and such other Persons who from time to time become party thereto, as amended, restated, supplemented or otherwise modified from time to time in accordance with its terms. 

“Transfer” means a transfer, sale, assignment, pledge, grant of a security interest in, encumbrance, hypothecation or other
disposition (including the creation of any derivative or synthetic interest, including a participation or other similar interest or any lien or encumbrance), in any case, whether by operation of Law or otherwise, and shall include any transaction
that is treated as a “transfer” within the meaning of Treasury Regulations Section 1.7704-1; and “Transferred,” “Transferee” and “Transferor” shall each have a
correlative meaning. 
 “Underwritten Public Offering” means an underwritten Public Offering, including any Block Trade
Offering. 
 “Underwritten Shelf Takedown” means an Underwritten Public Offering pursuant to an effective Shelf
Registration Statement. 
 “WKSI” means any Securities Act registrant that is a well-known seasoned issuer as defined in
Rule 405 under the Securities Act at the most recent eligibility determination date specified in paragraph (2) of that definition. 

Section 2.2 Other Terms. The following terms shall have the meaning specified in the indicated Section of this Agreement: 

 

			
	Agreement	  	Preamble
	Class B Common Stock	  	Recitals
	Common Stock	  	Recitals
	Company	  	Preamble
	Company Indemnitee	  	3.9.5

  
 5 

			
	Demand Notice	  	3.1.3
	Demand Registration	  	3.1.1(a)
	Demand Registration Request	  	3.1.1(a)
	Demand Registration Statement	  	3.1.1(c)
	Demand Suspension	  	3.1.6
	Ensemble	  	Recitals
	Innovations	  	Preamble
	Lock-Up Securities	  	3.4.2(a)
	Loss	  	3.9.1
	Operating Agreement	  	Recitals
	Participation Conditions	  	3.2.5(b)
	Piggyback Notice	  	3.3.1
	Piggyback Registration	  	3.3.1
	Potential Takedown Participant	  	3.2.5(b)
	Registration Expenses	  	3.8
	Restricted Period	  	3.4.1(a)
	Selling Stockholder Information	  	3.9.1
	Shelf Period	  	3.2.3
	Shelf Registration	  	3.2.1(a)
	Shelf Registration Notice	  	3.2.2
	Shelf Registration Request	  	3.2.1(a)
	Shelf Registration Statement	  	3.2.1(a)
	Shelf Suspension	  	3.2.4
	Shelf Takedown Notice	  	3.2.5(b)
	Shelf Takedown Request	  	3.2.5(a)

 Section 2.3 Other Interpretive Provisions. 

(a) The meanings of defined terms are equally applicable to the singular and plural forms of the defined terms. 

(b) The definitions in Section 2.1 and elsewhere in this Agreement shall apply equally to both the
singular and plural forms of the terms defined. 
 (c) Whenever the context may require, any pronoun shall include the
corresponding masculine, feminine and neuter forms. 
 (d) The words “hereof”, “herein” and
“hereunder” and words of like import used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. 

(e) The captions and headings of this Agreement are included for convenience of reference only and shall be ignored in the
construction or interpretation of this Agreement. 
 (f) References to Articles and Sections are to Articles and Sections of
this Agreement unless otherwise specified. 

  
 6 

 (g) The terms “include” and “including” are not limiting
and shall be deemed to be followed by the phrase “without limitation.” 
 (h) Whenever the words
“include”, “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation”, whether or not they are in fact followed by those
words or words of like import. 
 (i) “Writing”, “written” and comparable terms refer to printing, typing
and other means of reproducing words (including electronic media) in a visible form. 
 (j) The use of the word
“or” is not exclusive. 
 (k) The terms “Dollars” and “$” mean United States Dollars. 

(l) References from or through any date mean, unless otherwise specified, from and including or through and including,
respectively. 
 (m) Unless otherwise expressly provided herein, (i) any statute or law defined or referred to herein
means such statute or law as amended, and applicable rules and regulations thereunder, and any successor to such statute, rules or regulations, and any reference herein to a specific section, rule or regulation of such statute or law shall be deemed
to include any corresponding provisions of future law and (ii) any agreement or instrument defined or referred to herein means such agreement as amended, restated, supplemented or otherwise modified from time to time in accordance with its
terms (including by waiver or consent) and applicable law. 
 (n) Any time that a provision of this Agreement refers to a
threshold percentage of ownership of equity securities, such threshold percentage shall be equitably adjusted for any stock dividend, stock split, reverse stock split, combination of stock, reclassification, recapitalization or similar transaction.

 ARTICLE III 
 REGISTRATION
RIGHTS 
 The Company will perform and comply, and cause each of its subsidiaries to perform and comply, with such of the following
provisions as are applicable to it. Each Holder will perform and comply with such of the following provisions as are applicable to such Holder. 

Section 3.1 Demand Registration. 

Section 3.1.1 Request for Demand Registration. 

(a) Following the Effective Date, each of the GGC Investor and the BSMH Investor shall have the right to make a written request
from time to time to the Company for Registration of all or part of the Registrable Securities held by such Holder (a “Demand Registration Request”). Any Registration pursuant to a Demand Registration Request shall hereinafter be
referred to as a “Demand Registration.” Each such demand 

  
 7 

 
shall be required to be in respect of at least $50 million in anticipated aggregate net proceeds from all shares sold pursuant to such registration (including after giving effect to net
proceeds expected to be received by any Holder that participates in such offering after the delivery of written notice pursuant to Section 3.1.3 or otherwise) unless a lesser amount is then held by the initialing Holder, in
which case such demand may only be made in respect of all Registrable Securities held by such Holder. 
 (b) Each Demand
Registration Request shall specify (x) the aggregate amount of Registrable Securities to be registered and (y) the intended method or methods of disposition thereof. 

(c) Upon receipt of a Demand Registration Request, except as provided in Section 3.1.2, below, the
Company shall as promptly as practicable file a Registration Statement (a “Demand Registration Statement”) relating to such Demand Registration, and use its reasonable best efforts to cause such Demand Registration Statement to be
promptly declared effective under the Securities Act. 
 Section 3.1.2 Limitation on Demand Registrations. The Company shall not
be obligated to take any action to effect any Demand Registration if a Demand Registration was declared effective or an Underwritten Shelf Takedown was consummated within the same fiscal quarter as the request for a Demand Registration (unless
otherwise consented to by the Board of Directors of the Company); provided, however, that a Demand Registration shall not be counted for such purposes unless a Registration Statement that may be available at such time has become
effective and all of the Registrable Securities requested by the Demanding Holders to be registered on behalf of the Demanding Holders in such Registration Statement have been sold, in accordance with this Agreement. 

Section 3.1.3 Demand Notice. Promptly upon receipt of a Demand Registration Request pursuant to Section 3.1.1 (but in
no event more than one Business Day thereafter), the Company shall deliver a written notice (a “Demand Notice”) of any such Demand Registration Request to all other Holders and the Demand Notice shall offer each such Holder the
opportunity to include in the Demand Registration that number of Registrable Securities as each such Holder may request in writing. Subject to Section 3.1.7, the Company shall include in the Demand Registration all such
Registrable Securities with respect to which the Company has received written requests for inclusion therein within three Business Days after the date that the Demand Notice was delivered. 

Section 3.1.4 Demand Withdrawal. A Demanding Holder and any other Holder that has requested its Registrable Securities be included
in a Demand Registration pursuant to Section 3.1.3 may withdraw all or any portion of its Registrable Securities included in a Demand Registration from such Demand Registration at any time prior to the effectiveness of the
applicable Demand Registration and will not be obligated to participate in any Underwritten Public Offering prior to executing the underwriting agreement relating thereto. Upon receipt of a notice to such effect from a Demanding Holder (or if there
is more than one Demanding Holder, from all such Demanding Holders) with respect to all of the Registrable Securities included by such Demanding Holder(s) in such Demand Registration, the Company shall cease all efforts to secure effectiveness of
the applicable Demand Registration Statement; provided that, for the avoidance of doubt, in the 

  
 8 

 
event of a request for a Demand Registration by more than one Demanding Holder, the Company shall continue all efforts to secure effectiveness of the applicable Demand Registration Statement with
respect to the Registrable Securities requested to be included by each of the Holders that has not withdrawn its Registrable Securities. Notwithstanding any withdrawal by a Demanding Holder of Registrable Securities from a Demand Registration
pursuant to this Section 3.1.4, the Demand Registration with respect to which the withdrawal was made shall be counted for purposes of the limit on Demand Registration Requests set forth in
Section 3.1.2 unless (a) the Demanding Holders reimburse the Company for all expenses incurred in connection with the Demand Registration with respect to which the withdrawal was made, (b) the withdrawal is made
as a result of an event that has had a material adverse effect on the business, assets, condition (financial or otherwise) or results of operations of the Company or (c) the withdrawal is made in response to a Demand Suspension pursuant to
Section 3.1.6. 
 Section 3.1.5 Effective Registration. The Company shall use reasonable best efforts
to cause a Demand Registration Statement to become effective and remain effective for not less than 180 days plus the duration of any suspension period (or such shorter period as will terminate when all Registrable Securities covered by such Demand
Registration Statement have been sold or withdrawn), or, if such Demand Registration Statement relates to an Underwritten Public Offering, such longer period as in the opinion of counsel for the underwriter or underwriters a Prospectus is required
by law to be delivered in connection with sales of Registrable Securities by an underwriter or dealer. 
 Section 3.1.6 Delay in
Filing; Suspension of Registration. If the filing, initial effectiveness or continued use of a Demand Registration Statement at any time would require the Company to make an Adverse Disclosure, the Company may, upon giving prompt written notice
of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, the Demand Registration Statement (a “Demand Suspension”); provided, however, that the Company shall not be permitted to
exercise a Demand Suspension (i) more than once during any 12-month period or (ii) for a period exceeding 60 days. In the case of a Demand Suspension, the Holders agree to suspend use of the
applicable Prospectus in connection with any sale or purchase, or offer to sell or purchase, Registrable Securities, upon receipt of the notice referred to above. The Company shall immediately notify the Holders in writing upon (a) the
Company’s decision to file or seek effectiveness of such Demand Registration Statement following such Demand Suspension and (b) the effectiveness of such Demand Registration Statement. Notwithstanding the provisions of this
Section 3.1.6, the Company may not postpone the filing or effectiveness of, or suspend use of, a Demand Registration Statement past the date upon which the applicable Adverse Disclosure is disclosed to the public or ceases to be
material. During a Demand Suspension, the Company shall be prohibited from filing a registration statement for its own account or for the account of any other Holder or holder of its securities and, upon termination of any Demand Suspension, the
Company shall promptly amend or supplement the Prospectus, if necessary, so it does not contain any untrue statement or omission and furnish to the Holders such numbers of copies of the Prospectus as so amended or supplemented as the Holders may
reasonably request. The Company shall, if necessary, supplement or amend the Demand Registration Statement, if required by the registration form used by the Company for the Demand Registration or by the instructions applicable to such registration
form or by the Securities Act or the rules or regulations promulgated thereunder or as may reasonably be requested by any of the GGC Investor or the BSMH Investor that is participating in such Demand Registration. 

  
 9 

 Section 3.1.7 Priority of Securities Registered Pursuant to Demand
Registrations. If the managing underwriter or underwriters of a proposed Underwritten Public Offering of the Registrable Securities included in a Demand Registration advise the Company in writing that, in its or their opinion, the number of
securities requested to be included in such Demand Registration exceeds the number that can be sold in such offering without being likely to have an adverse effect on the price, timing or distribution of the securities offered or the market for the
securities offered, then the securities to be included in such Registration shall be in the case of any Demand Registration allocated to each Holder that has requested to participate in such Demand Registration an amount equal to the lesser of
(i) the number of such Registrable Securities requested to be registered or sold by such Holder, and (ii) a number of such shares equal to such Holder’s Pro Rata Portion. 

Section 3.2 Shelf Registration. 

Section 3.2.1 Request for Shelf Registration. 

(a) Upon the written request of any of the Principal Stockholders from time to time following the date on which the Company
becomes eligible to use Form S-3 or any similar short-form registration statement (a “Shelf Registration Request”), the Company shall promptly file with the SEC a shelf Registration Statement
pursuant to Rule 415 under the Securities Act (“Shelf Registration Statement”) relating to the offer and sale of Registrable Securities by any Holders thereof from time to time in accordance with the methods of distribution elected
by such Holders and the Company shall use its reasonable best efforts to cause such Shelf Registration Statement to promptly become effective under the Securities Act. Any such Registration pursuant to a Shelf Registration Request shall hereinafter
be referred to as a “Shelf Registration.” 
 (b) If on the date of the Shelf Registration Request the
Company is a WKSI, then the Shelf Registration Request may request Registration of an unspecified amount of Registrable Securities to be sold by unspecified Holders. If on the date of the Shelf Registration Request the Company is not a WKSI, then
the Shelf Registration Request shall specify the aggregate amount of Registrable Securities to be registered. The Company shall provide to the Principal Stockholders the information necessary to determine the Company’s status as a WKSI upon
request. 
 Section 3.2.2 Shelf Registration Notice. Promptly upon receipt of a Shelf Registration Request (but in no event more
than one Business Day thereafter), the Company shall deliver a written notice (a “Shelf Registration Notice”) of any such request to all other Holders, which notice shall specify, if applicable, the amount of Registrable Securities
to be registered, and the Shelf Registration Notice shall offer each such Holder the opportunity to include in the Shelf Registration that number of Registrable Securities as each such Holder may request in writing. Subject to
Section 3.2.7, the Company shall include in such Shelf Registration all such Registrable Securities with respect to which the Company has received written requests for inclusion therein within three Business Days (or within twenty-four
hours in the case of a Block Trade Offering) after the date that the Shelf Registration Notice has been delivered to such Holder. 

  
 10 

 Section 3.2.3 Continued Effectiveness. The Company shall use its reasonable best
efforts to keep such Shelf Registration Statement continuously effective under the Securities Act in order to permit the Prospectus forming part of the Shelf Registration Statement to be usable by Holders until the earlier of: (i) the date as
of which all Registrable Securities have been sold pursuant to the Shelf Registration Statement or another Registration Statement filed under the Securities Act (but in no event prior to the applicable period referred to in Section 4(a)(3) of
the Securities Act and Rule 174 thereunder); and (ii) the date as of which no Holder holds Registrable Securities (such period of effectiveness, the “Shelf Period”). 

Section 3.2.4 Suspension of Registration. If the continued use of such Shelf Registration Statement at any time would require the
Company to make an Adverse Disclosure, the Company may, upon giving prompt written notice of such action to the Holders, suspend use of the Shelf Registration Statement (a “Shelf Suspension”); provided, however, that
the Company shall not be permitted to exercise a Shelf Suspension (i) more than one time during any 12-month period, or (ii) for a period exceeding 60 days. In the case of a Shelf Suspension, the
Holders agree to suspend use of the applicable Prospectus in connection with any sale or purchase of, or offer to sell or purchase, Registrable Securities, upon receipt of the notice referred to above. The Company shall immediately notify the
Holders in writing upon the termination of any Shelf Suspension, and upon such termination, promptly amend or supplement the Prospectus, if necessary, so it does not contain any untrue statement or omission and furnish to the Holders such numbers of
copies of the Prospectus as so amended or supplemented as the Holders may reasonably request. The Company shall, if necessary, supplement or amend the Shelf Registration Statement, if required by the registration form used by the Company for the
Shelf Registration Statement or by the instructions applicable to such registration form or by the Securities Act or the rules or regulations promulgated thereunder or as may reasonably be requested by the Holders of a majority of Registrable
Securities that are included in such Shelf Registration Statement. 
 Section 3.2.5 Shelf Takedown. 

(a) At any time during which the Company has an effective Shelf Registration Statement with respect to Registrable Securities
held by any of the Principal Stockholders or is a WKSI, by notice to the Company specifying the intended method or methods of disposition thereof, such Holder may make a written request (a “Shelf Takedown Request”) to the Company to
effect a Public Offering, including an Underwritten Shelf Takedown, of all or a portion of such Holder’s Registrable Securities that are covered by such Shelf Registration Statement, and as soon as practicable the Company shall amend or
supplement the Shelf Registration Statement for such purpose; provided, that any Underwritten Shelf Takedown Request shall be required to be in respect of at least $50 million in anticipated net proceeds in the aggregate (including after
giving effect to net proceeds expected to be received by any Holder that participates in such offering after delivery of a written notice provided for in Section 3.2.5(b), unless a lesser amount is then held by the
initiating Holder, in which case, such request may be made only in respect of all Registrable Securities held by such Holder. 

  
 11 

 (b) Subject to Section 3.2.6, promptly upon
receipt of a Shelf Takedown Request (but in no event more than three Business Days thereafter) for any Underwritten Shelf Takedown, the Company shall deliver a notice (a “Shelf Takedown Notice”) to each other Holder with Registrable
Securities covered by the applicable Registration Statement, or to all other Holders if such Registration Statement is undesignated (each a “Potential Takedown Participant”). The Shelf Takedown Notice shall offer each such Potential
Takedown Participant the opportunity to include in any Underwritten Shelf Takedown such number of Registrable Securities as each such Potential Takedown Participant may request in writing. Subject to Section 3.2.7, the
Company shall include in the Underwritten Shelf Takedown all such Registrable Securities with respect to which the Company has received written requests for inclusion therein within three Business Days after the date that the Shelf Takedown Notice
has been delivered to such Holder (or within twenty-four hours after the time that the Shelf Takedown Notice has been delivered to such Holder if such notice relates to a Block Trade Offering). Any Potential Takedown Participant’s request to
participate in an Underwritten Shelf Takedown shall be binding on the Potential Takedown Participant upon execution of the Underwriting Agreement in respect of such Underwritten Shelf Takedown; provided, however, that, in a Block Trade
Offering, each such Potential Takedown Participant that elects to participate may condition its participation on such Block Trade Offering being completed (i) within one (1) Business Day of its acceptance and (ii) at a price per share
(after giving effect to any underwriters’ discounts or commissions) to such Potential Takedown Participant of not less than 92% (or such lesser percentage specified by such Potential Takedown Participant in writing) of the closing price for the
shares on their principal trading market on the Business Day immediately prior to such Block Trade Offering (the “Participation Conditions”). Notwithstanding the delivery of any Shelf Takedown Notice, but subject to the
Participation Conditions in any Block Trade Offering, all determinations as to whether to complete any Underwritten Shelf Takedown and as to the timing, manner, price, size and other terms of any Underwritten Shelf Takedown contemplated by this
Section 3.2.5 shall be determined by the Principal Stockholder selling the greatest number of Registrable Securities. 

Section 3.2.6 The Company shall not be obligated to take any action to effect any Underwritten Shelf Takedown if a Demand Registration
was declared effective or an Underwritten Shelf Takedown was consummated within the same fiscal quarter as the request for a Demand Registration (unless otherwise consented to by the Board of Directors of the Company);
provided, however, that a Demand Registration shall not be counted for such purposes unless a Registration Statement that may be available at such time has become effective and all of the Registrable Securities requested by the
Demanding Holders to be registered on behalf of the Demanding Holders in such Registration Statement have been sold, in accordance with this Agreement. 

Section 3.2.7 Priority of Securities Sold Pursuant to Shelf Takedowns. If the managing underwriter or underwriters of a proposed
Underwritten Shelf Takedown pursuant to Section 3.2.5 advise the Company in writing that, in its or their opinion, the number of securities requested to be included in the proposed Underwritten Shelf Takedown exceeds the
number that can be sold in such Underwritten Shelf Takedown without being likely to have an adverse effect on the price, timing or distribution of the securities offered or the market for the securities offered, the number of Registrable Securities
to be included in such offering shall be allocated to each Holder that has requested to participate in such Underwritten Shelf Takedown an amount equal to the lesser of (i) the number of such Registrable Securities requested to be registered or
sold by such Holder, and (ii) a number of such shares equal to such Holder’s Pro Rata Portion. 

  
 12 

 Section 3.3 Piggyback Registration. 

Section 3.3.1 Participation. If the Company at any time proposes to file a Registration Statement under the Securities Act or to
conduct a Public Offering with respect to any offering of its equity securities for its own account or for the account of any other Persons (other than an Excluded Registration or a Registration pursuant to Sections 3.1 or
3.2), then, as soon as practicable (but in no event less than five Business Days prior to (x) the proposed date of filing of such Registration Statement or, in the case of any such Public Offering under a Shelf Registration Statement,
(y) the anticipated pricing or trade date), the Company shall give written notice (a “Piggyback Notice”) of such proposed filing or Public Offering to all Holders, and such Piggyback Notice shall offer the Holders the
opportunity to register under such Registration Statement, or to sell in such Public Offering, such number of Registrable Securities as each such Holder may request in writing (a “Piggyback Registration”). Subject to
Section 3.3.2, the Company shall include in such Registration Statement or in such Public Offering as applicable, all such Registrable Securities that are requested to be included therein within three Business Days after
the receipt by such Holder of any such notice; provided, however, that if at any time after giving written notice of its intention to register or sell any securities and prior to the effective date of the Registration Statement filed
in connection with such Registration, or the pricing or trade date of a Public Offering under a Shelf Registration Statement, the Company shall determine for any reason not to register or sell or to delay Registration or the sale of such securities,
the Company shall promptly give written notice of such determination to each Holder and, thereupon, (i) in the case of a determination not to register or sell, the Company shall be relieved of its obligation to register or sell any Registrable
Securities in connection with such Registration or Public Offering (but not from its obligation to pay the Registration Expenses in connection therewith), without prejudice, however, to the rights of any Holders entitled to request that such
Registration or sale be effected as a Demand Registration under Section 3.1 or an Underwritten Shelf Takedown under Section 3.2, as the case may be, and (ii) in the case of a determination to
delay Registration or sale, in the absence of a request for a Demand Registration or an Underwritten Shelf Takedown, as the case may be, the Company shall be permitted to delay registering or selling any Registrable Securities, for the same period
as the delay in registering or selling such other securities. If the offering pursuant to such Registration Statement or Public Offering is to be an Underwritten Public Offering, then each Holder making a request for a Piggyback Registration
pursuant to this Section 3.3.1 shall, and the Company shall, make such arrangements with the managing underwriter or underwriters so that each such Holder may, participate in such underwritten offering. If the offering
pursuant to such Registration Statement or Public Offering is to be on any other basis, then each Holder making a request for a Piggyback Registration pursuant to this Section 3.3.1 shall be permitted to, and the Company
shall, make such arrangements so that each such Holder may participate in such offering on such basis. Any Holder shall have the right to withdraw all or part of its request for inclusion of its Registrable Securities in a Piggyback Registration by
giving written notice to the Company of its request to withdraw; provided that such request must be made in writing prior to the execution of the related underwriting agreement or the effectiveness of the Registration Statement, as
applicable. 

  
 13 

 Section 3.3.2 Priority of Piggyback Registration. If the managing underwriter or
underwriters of any proposed offering of Registrable Securities included in a Piggyback Registration informs the Company and the participating Holders in writing that, in its or their opinion, the number of securities that such Holders and any other
Persons intend to include in such offering exceeds the number that can be sold in such offering without being likely to have a significant adverse effect on the price, timing or distribution of the securities offered or the market for the securities
offered, then the securities to be included in such Registration shall be (i) first, 100% of the securities that the Company proposes to sell and (ii) second, and only if all the securities referred to in clause (i) have been
included, the number of Registrable Securities that, in the opinion of such managing underwriter or underwriters, can be sold without having such adverse effect, with such number to be allocated among the Holders that have requested to participate
in such Registration based on an amount equal to the lesser of (A) the number of such Registrable Securities requested to be sold by such Holder, and (B) a number of such shares equal to such Holder’s Pro Rata Portion. 

Section 3.3.3 No Effect on Other Registrations. No Registration of Registrable Securities effected pursuant to a request under
this Section 3.3 shall be deemed to have been effected pursuant to Sections 3.1 and 3.2 or shall relieve the Company of its obligations under Sections 3.1 and
3.2. 
 Section 3.4 Lock-Up Agreements. 

Section 3.4.1 In connection with each Registration or sale of Registrable Securities pursuant to Section 3.1,
3.2 or 3.3 conducted as an Underwritten Public Offering, if requested by the underwriters for such Underwritten Public Offering, each Holder shall, and the Company shall and shall cause each of its directors and executive officers to,
enter into a customary lock-up agreement for a period of 90 days. 
 Section 3.4.2
Notwithstanding the foregoing: 
 (a) The BSMH Investor agrees, on behalf of itself and its Permitted Transferees that hold Lock-up Securities, that for a period of one (1) year) following the date of the final prospectus for the IPO (the “Restricted Period”), except for any
Pre-Approved Transfer, it and its Permitted Transferees that hold Lock-up Securities will not, (i) offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Class A Common Stock, LLC Units or any securities
convertible into or exercisable or exchangeable (directly or indirectly) for Class A Common Stock (whether such shares or any such securities are then owned by such Person or are thereafter acquired) (collectively, the “Lock-Up Securities”) or (ii) enter into any swap or other arrangement or transaction that transfers to another Person, in whole or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of the Lock-Up Securities, in cash or otherwise; and

 (b) Prior to the fifth anniversary of the Closing, the BSMH Investor hereby agrees, on behalf of itself and its Permitted
Transferees that hold Lock-up Securities, not to, in any calendar year, without the prior written consent of the GGC Investor (for so long as such member holds LLC Units or Common Stock) and the Company,
except in a Pre-Approved Transfer (i) offer, pledge, sell, contract to sell, sell 

  
 14 

 
any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any
Lock-Up Securities representing in excess of, in the aggregate, 10% of the total number of Lock-up Securities held by the BSMH Investor as of the beginning of such
calendar year or (ii) enter into any swap or other arrangement or transaction that transfers to another Person, in whole or in part, any of the economic consequences of ownership of Lock-Up Securities in
excess of, in the aggregate, 10% of the total number of Lock-up Securities held by the BSMH Investor as of the beginning of such calendar year; provided, that nothing in this
Section 3.4.2 shall prohibit the BSMH Investor or any of its Permitted Transferees from effecting an Redemption in accordance with Section 9.01 of the Operating Agreement. 

Section 3.5 Registration Procedures. 

Section 3.5.1 Requirements. In connection with the Company’s obligations under Sections 3.1,
3.2 and 3.3, the Company shall use its reasonable best efforts to effect such Registration and to permit the sale of such Registrable Securities in accordance with the intended method or methods of distribution thereof as expeditiously
as reasonably practicable, and in connection therewith the Company shall: 
 (a) as promptly as is reasonably practicable
prepare and file the required Registration Statement, including all exhibits and financial statements required under the Securities Act to be filed therewith and Prospectus, and, before filing a Registration Statement or Prospectus or any amendments
or supplements thereto, (x) furnish to the underwriters, if any, and to the Holders of the Registrable Securities covered by such Registration Statement, copies of all documents prepared to be filed, which documents shall be subject to the
review of such underwriters and such Holders and their respective counsel, (y) subject to applicable law, make such changes in such documents concerning the Holders prior to the filing thereof as such Holders, or their counsel, may reasonably
request and (z) subject to applicable law, except in the case of a Registration under Section 3.3, not file any Registration Statement or Prospectus or amendments or supplements thereto to which any participating
Principal Stockholder or the underwriters, if any, shall reasonably object; 
 (b) as promptly as is reasonably practicable
prepare and file with the SEC such amendments and post-effective amendments to such Registration Statement and supplements to the Prospectus as may be (x) reasonably requested by any Principal Stockholder with Registrable Securities covered by
such Registration Statement, (y) reasonably requested by any participating Holder (to the extent such request relates to information relating to such Holder), or (z) necessary to keep such Registration Statement effective for the period of
time required by this Agreement, and comply with provisions of the applicable securities laws with respect to the sale or other disposition of all securities covered by such Registration Statement during such period in accordance with the intended
method or methods of disposition by the sellers thereof set forth in such Registration Statement; 

  
 15 

 (c) notify the participating Holders and the managing underwriter or
underwriters, if any, and (if requested) confirm such notice in writing and provide copies of the relevant documents, as soon as reasonably practicable after notice thereof is received by the Company (v) when the applicable Registration
Statement or any amendment thereto has been filed or becomes effective, and when the applicable Prospectus or any amendment or supplement thereto has been filed, (w) of any written comments by the SEC, or any request by the SEC or other federal
or state governmental authority for amendments or supplements to such Registration Statement or such Prospectus, or for additional information (whether before or after the effective date of the Registration Statement) or any other correspondence
with the SEC relating to, or which may affect, the Registration, (x) of the issuance by the SEC of any stop order suspending the effectiveness of such Registration Statement or any order by the SEC or any other regulatory authority preventing
or suspending the use of any preliminary or final Prospectus or the initiation or threatening of any proceedings for such purposes, (y) if, at any time, the representations and warranties of the Company in any applicable underwriting agreement
cease to be true and correct in all material respects and (z) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Registrable Securities for offering or sale in any jurisdiction or the
initiation or threatening of any proceeding for such purpose; 
 (d) promptly notify each selling Holder and the managing
underwriter or underwriters, if any, when the Company becomes aware of the happening of any event as a result of which the applicable Registration Statement or the Prospectus included in such Registration Statement (as then in effect) contains any
untrue statement of a material fact or omits to state a material fact necessary to make the statements therein (in the case of such Prospectus or any preliminary Prospectus, in light of the circumstances under which they were made) not misleading,
when any Issuer Free Writing Prospectus includes information that may conflict with the information contained in the Registration Statement, or, if for any other reason it shall be necessary during such time period to amend or supplement such
Registration Statement or Prospectus in order to comply with the Securities Act and, as promptly as reasonably practicable thereafter, prepare and file with the SEC, and furnish without charge to the selling Holders and the managing underwriter or
underwriters, if any, an amendment or supplement to such Registration Statement or Prospectus, which shall correct such misstatement or omission or effect such compliance; 

(e) to the extent the Company is eligible under the relevant provisions of Rule 430B under the Securities Act, if the Company
files any Shelf Registration Statement, the Company shall include in such Shelf Registration Statement such disclosures as may be required by Rule 430B under the Securities Act (referring to the unnamed selling security holders in a generic manner
by identifying the initial offering of the securities to the Holders) in order to ensure that the Holders may be added to such Shelf Registration Statement at a later time through the filing of a Prospectus supplement rather than a post-effective
amendment; 
 (f) use its commercially reasonable efforts to prevent, or obtain the withdrawal of, any stop order or other
order or notice preventing or suspending the use of any preliminary or final Prospectus; 

  
 16 

 (g) promptly incorporate in a Prospectus supplement, Issuer Free Writing
Prospectus or post-effective amendment such information as the managing underwriter or underwriters and the Holders of a majority of Registrable Securities being sold agree should be included therein relating to the plan of distribution with respect
to such Registrable Securities; and make all required filings of such Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment as soon as reasonably practicable after being notified of the matters to be incorporated in such
Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment; 
 (h) furnish to each selling Holder and
each underwriter, if any, without charge, as many conformed copies as such Holder or underwriter may reasonably request of the applicable Registration Statement and any amendment or post-effective amendment or supplement thereto, including financial
statements and schedules, all documents incorporated therein by reference and all exhibits (including those incorporated by reference); 

(i) deliver to each selling Holder and each underwriter, if any, without charge, as many copies of the applicable Prospectus
(including each preliminary Prospectus) and any amendment or supplement thereto and such other documents as such Holder or underwriter may reasonably request in order to facilitate the disposition of the Registrable Securities by such Holder or
underwriter (it being understood that the Company shall consent to the use of such Prospectus or any amendment or supplement thereto by each of the selling Holders and the underwriters, if any, in connection with the offering and sale of the
Registrable Securities covered by such Prospectus or any amendment or supplement thereto); 
 (j) on or prior to the date on
which the applicable Registration Statement becomes effective, use its commercially reasonable efforts to register or qualify, and cooperate with the selling Holders, the managing underwriter or underwriters, if any, and their respective counsel, in
connection with the Registration or qualification of such Registrable Securities for offer and sale under the securities or “Blue Sky” laws of each state and other jurisdiction as any such selling Holder or managing underwriter or
underwriters, if any, or their respective counsel reasonably request in writing and do any and all other acts or things reasonably necessary or advisable to keep such Registration or qualification in effect for such period as required by
Section 3.1 or Section 3.2, as applicable; provided that the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified or to
take any action which would subject it to taxation or general service of process in any such jurisdiction where it is not then so subject; 

(k) cooperate with the selling Holders and the managing underwriter or underwriters, if any, to enable such Registrable
Securities to be in such denominations and registered in such names as the managing underwriters may request prior to any sale of Registrable Securities to the underwriters; 

  
 17 

 (l) use its commercially reasonable efforts to cause the Registrable
Securities covered by the applicable Registration Statement to be registered with or approved by such other governmental agencies or authorities as may be necessary to enable the seller or sellers thereof or the underwriter or underwriters, if any,
to consummate the disposition of such Registrable Securities; 
 (m) not later than the effective date of the applicable
Registration Statement, provide a CUSIP number for all Registrable Securities if other than the CUSIP for the publicly traded Class A Common Stock and if one has then been assigned; 

(n) make such representations and warranties to the Holders of Registrable Securities being registered, and the underwriters or
agents, if any, in form, substance and scope as are customarily made by issuers in public offerings similar to the offering then being undertaken; 

(o) enter into such customary agreements (including underwriting and indemnification agreements) and take all such other
actions as any participating Principal Stockholder or the managing underwriter or underwriters, if any, reasonably request in order to expedite or facilitate the Registration and disposition of such Registrable Securities; 

(p) obtain for delivery to the underwriter or underwriters, if any, an opinion or opinions from counsel for the Company dated
the most recent effective date of the Registration Statement or, in the event of an Underwritten Public Offering, the date of the closing under the underwriting agreement, in customary form, scope and substance, which opinions shall be reasonably
satisfactory to the underwriter or underwriters and its or their counsel; 
 (q) in the case of an Underwritten Public
Offering, obtain for delivery to the Company and the managing underwriter or underwriters, with copies to the Holders included in such Registration or sale, a comfort letter from the Company’s independent certified public accountants or
independent auditors (and, if necessary, any other independent certified public accountants or independent auditors of any subsidiary of the Company or any business acquired by the Company for which financial statements and financial data are, or
are required to be, included in the Registration Statement) in customary form and covering such matters of the type customarily covered by comfort letters as the managing underwriter or underwriters reasonably request, dated the date of execution of
the underwriting agreement and brought down to the closing under the underwriting agreement; 
 (r) cooperate with each
seller of Registrable Securities and each underwriter, if any, participating in the disposition of such Registrable Securities and their respective counsel in connection with any filings required to be made with FINRA; 

(s) use its reasonable best efforts to comply with all applicable securities laws and, if a Registration Statement was filed,
make available, including through the SEC’s EDGAR filing system or any successor system, to its security holders, as soon as reasonably practicable, an earnings statement satisfying the provisions of Section 11(a) of the Securities Act and
the rules and regulations promulgated thereunder; 

  
 18 

 (t) provide and cause to be maintained a transfer agent and registrar for
all Registrable Securities covered by the applicable Registration Statement from and after a date not later than the effective date of such Registration Statement; 

(u) use its commercially reasonable efforts to cause all Class A Common Stock covered by the applicable Registration
Statement to be listed on the securities exchange on which the Company’s Class A Common Stock is then listed or quoted and on each inter-dealer quotation system on which the Company’s Class A Common Stock is then quoted; 

(v) make available upon reasonable notice at reasonable times and for reasonable periods for inspection by any representative
appointed by the participating Principal Stockholders, by any underwriter participating in any disposition to be effected pursuant to such Registration Statement or by any attorney, accountant or other agent retained by such Holders or any such
underwriter, all pertinent financial and other records and pertinent corporate documents and properties of the Company, and cause all of the Company’s officers, directors and employees and the independent public accountants who have certified
its financial statements to make themselves available to discuss the business of the Company and to supply all information reasonably requested by any such Person in connection with such Registration Statement; 

(w) in the case of an Underwritten Public Offering, cause the senior executive officers of the Company to participate in the
customary “road show” presentations that may be reasonably requested by the managing underwriter or underwriters in any such offering and otherwise to facilitate, cooperate with, and participate in each proposed offering contemplated
herein and customary selling efforts related thereto; 
 (x) take no direct or indirect action prohibited by Regulation M
under the Exchange Act; 
 (y) take all reasonable action to ensure that any Issuer Free Writing Prospectus utilized in
connection with any Registration complies in all material respects with the Securities Act, is filed in accordance with the Securities Act to the extent required thereby, is retained in accordance with the Securities Act to the extent required
thereby and, when taken together with the related Prospectus, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were
made, not misleading; and 
 (z) take all such other reasonable actions as are necessary or advisable in order to expedite or
facilitate the disposition of such Registrable Securities in accordance with the terms of this Agreement. 
 Section 3.5.2 Company
Information Requests. The Company may require each seller of Registrable Securities as to which any Registration or sale is being effected to furnish to the Company such information regarding the distribution of such securities and such other
information relating to such Holder and its ownership of Registrable Securities as the Company 

  
 19 

 
may from time to time reasonably request in writing and the Company may exclude from such Registration or sale the Registrable Securities of any such Holder who unreasonably fails to furnish such
information within a reasonable time after receiving such request. Each Holder agrees to furnish such information to the Company and to cooperate with the Company as reasonably necessary to enable the Company to comply with the provisions of this
Agreement. 
 Section 3.5.3 Discontinuing Registration. Each Holder agrees that, as promptly as possible after receipt of any
notice from the Company of the happening of any event of the kind described in Section 3.5.1(d), such Holder will forthwith discontinue disposition of Registrable Securities pursuant to such Registration Statement until
such Holder’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 3.5.1(d), or until such Holder is advised in writing by the Company that the use of the Prospectus may be resumed,
and has received copies of any additional or supplemental filings that are incorporated by reference in the Prospectus, or any amendments or supplements thereto, and if so directed by the Company, such Holder shall deliver to the Company (at the
Company’s expense) all copies, other than permanent file copies then in such Holder’s possession, of the Prospectus covering such Registrable Securities current at the time of receipt of such notice. In the event the Company shall give any
such notice, the period during which the applicable Registration Statement is required to be maintained effective shall be extended by the number of days during the period from and including the date of the giving of such notice to and including the
date when each seller of Registrable Securities covered by such Registration Statement either receives the copies of the supplemented or amended Prospectus contemplated by Section 3.5.1(d) or is advised in writing by the
Company that the use of the Prospectus may be resumed. 
 Section 3.6 Underwritten Offerings. 

Section 3.6.1 Shelf and Demand Registrations. If requested by the underwriters for any Underwritten Public Offering, pursuant to a
Registration or sale under Section 3.1 or 3.2, the Company shall enter into an underwriting agreement with such underwriters, such agreement to be reasonably satisfactory in substance and form to each of the Company,
each Principal Stockholder seeking to participate in such offering and the underwriters, and containing a requirement to obtain lock-up agreements from directors and executive officers of the Company and such
other terms as are generally prevailing in agreements of that type. The Holders of the Registrable Securities proposed to be distributed by such underwriters shall cooperate as reasonably necessary with the Company in the negotiation of the
underwriting agreement and shall give consideration to the reasonable suggestions of the Company regarding the form thereof. Such Holders shall be parties to such underwriting agreement, which shall contain such agreements on the part of the Company
to and for the benefit of such Holders as are customarily made by issuers to selling stockholders in public offerings similar to the applicable offering. Any such Holder shall be required to make representations and warranties and other agreements,
deliver an opinion or opinions from its counsel and provide indemnities, in each case as are customarily made by selling stockholders in secondary public offerings. 

Section 3.6.2 Piggyback Registrations. If the Company proposes to register or sell any of its securities under the Securities Act
as contemplated by Section 3.3 and such securities are to be distributed through one or more underwriters, the Company shall, if requested by any Holder pursuant to Section 3.3 and, subject to the
provisions of Section 3.3.2, use its commercially 

  
 20 

 
reasonable efforts to arrange for such underwriters to include on the same terms and conditions that apply to the other sellers in such Registration or sale all the Registrable Securities to be
offered and sold by such Holder among the securities of the Company to be distributed by such underwriters in such Registration or sale. The Holders of Registrable Securities to be distributed by such underwriters shall be parties to the
underwriting agreement between the Company and such underwriters, which underwriting agreement shall contain such representations and warranties by, and the other agreements on the part of, the Company to and for the benefit of such Holders as are
customarily made by issuers to selling stockholders in secondary public offerings. Any such Holder shall be required to make representations and warranties and other agreements, deliver an opinion or opinions from its counsel and provide
indemnities, in each case as are customarily made by selling stockholders in secondary public offerings. 
 Section 3.6.3
Participation in Underwritten Registrations. Subject to the provisions of Section 3.6.1 and Section 3.6.2 above, no Person may participate in any Underwritten Public Offering hereunder
unless such Person (i) agrees to sell such Person’s securities on the basis provided in any underwriting arrangements approved by the Persons entitled to approve such arrangements and (ii) completes and executes all questionnaires,
powers of attorney, indemnities, underwriting agreements and other documents as reasonably required under the terms of such underwriting arrangements; provided that any such Holder shall not be required to make any representations or
warranties to or agreements with the Company other than representations, warranties or agreements regarding such Holder, such Holder’s title to the Registrable Securities, such Holder’s intended method of distribution and any other
representations to be made by the Holder as are generally prevailing in agreements of that type, and the aggregate amount of the liability of such Holder shall not exceed such Holder’s proceeds from the sale of its Registrable Securities in the
offering, net of underwriting discounts and commissions but before expenses. 
 Section 3.6.4 Selection of Underwriters. In the
case of an Underwritten Public Offering under Section 3.1, 3.2 or 3.3 the managing underwriter or underwriters to administer the offering shall be determined by the Company, taking into consideration
recommendations of any Principal Stockholder(s) participating in the offering; provided that (i) any Principal Stockholder whose Registrable Securities comprise at least 20% of the offering shall have the right to select the managing
underwriter or underwriters in connection with such Underwritten Public Offering and (ii) if both Principal Stockholders are participants, then the Principal Stockholder registering the most Registrable Securities in such Underwritten Public
Offering shall have the right to select the managing underwriter or underwriters in such Underwritten Public Offering. 
 Section 3.7
No Inconsistent Agreements; Additional Rights. Neither the Company nor any of its subsidiaries shall hereafter enter into, and neither the Company nor any of its subsidiaries is currently a party to, any agreement with respect to its
securities that is inconsistent with the rights granted to the Holders by this Agreement. Without Requisite Investor Approval, neither the Company nor any of its subsidiaries shall enter into any agreement granting registration or similar rights to
any Person that are prior in right, pari passu or inconsistent with the rights under this Agreement, and the Company hereby represents and warrants that, as of the date hereof, no registration or similar rights have been granted to any other Person
other than pursuant to this Agreement. 

  
 21 

 Section 3.8 Registration Expenses. All expenses incident to the Company’s
performance of or compliance with this Agreement shall be paid by the Company, including (i) all registration and filing fees, and any other fees and expenses associated with filings required to be made with the SEC or FINRA, (ii) all fees
and expenses in connection with compliance with any securities or “Blue Sky” laws (including reasonable fees and disbursements of counsel for the underwriters in connection with blue sky qualifications of the Registrable Securities),
(iii) all printing, duplicating, word processing, messenger, telephone, facsimile and delivery expenses of the Company (including expenses of printing certificates for the Registrable Securities in a form eligible for deposit with The
Depository Trust Company and of printing Prospectuses), (iv) all fees and disbursements of counsel for the Company and of all independent certified public accountants or independent auditors of the Company and any subsidiaries of the Company
(including the expenses of any special audit and comfort letters required by or incident to such performance), (v) Securities Act liability insurance or similar insurance if the Company so desires, (vi) all fees and expenses incurred in
connection with the listing of the Registrable Securities on any securities exchange or quotation of the Registrable Securities on any inter-dealer quotation system, (vii) all applicable rating agency fees with respect to the Registrable
Securities, (viii) all reasonable fees and disbursements of one counsel for the Principal Stockholders, including all reasonable fees for an opinion from counsel to each such participating Principal Stockholder and any required local counsel
opinions, (ix) all fees and expenses of any special experts or other Persons retained by the Company in connection with any Registration or sale, (x) all of the Company’s internal expenses (including all salaries and expenses of its
officers and employees performing legal or accounting duties) and (xi) all expenses of the Company related to the “road-show” for any Underwritten Public Offering. All such expenses are referred to herein as “Registration
Expenses.” The Company shall not be required to pay any fees and disbursements to underwriters not customarily paid by the issuers of securities in an offering similar to the applicable offering, including underwriting discounts and commissions
and transfer taxes, if any, attributable to the sale of Registrable Securities, which shall be paid by the participating Holders in proportion to the number of Registrable Securities offered and sold by or on behalf of each such Holder. 

Section 3.9 Indemnification. 

Section 3.9.1 Indemnification by the Company. The Company shall indemnify and hold harmless, to the full extent permitted by law,
each Holder, each shareholder, member, limited or general partner of such Holder, each shareholder, member, limited or general partner of each such shareholder, member, limited or general partner, each of their respective Affiliates, officers,
directors, shareholders, employees, advisors, and agents and each Person who controls (within the meaning of the Securities Act or the Exchange Act) such Persons and each of their respective Representatives from and against any and all losses,
penalties, judgments, suits, costs, claims, damages, liabilities and expenses, joint or several (including reasonable costs of investigation and legal expenses) (each, a “Loss” and collectively “Losses”) arising out
of or based upon (i) any untrue or alleged untrue statement of a material fact contained in any Registration Statement under which such Registrable Securities are registered or sold under the Securities Act (including any final, preliminary or
summary Prospectus contained therein or any amendment thereof or supplement thereto or any documents incorporated by reference therein) or any other disclosure document produced by or on behalf of the Company or any of its subsidiaries including any
report or other document filed under the Exchange Act, (ii) any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements 

  
 22 

 
therein (in the case of a Prospectus or preliminary Prospectus, in light of the circumstances under which they were made) not misleading or (iii) any violation or alleged violation by the
Company or any of its subsidiaries of any federal, state, foreign or common law rule or regulation applicable to the Company or any of its subsidiaries and relating to action or inaction in connection with any such registration, disclosure document
or other document or report; provided, that no selling Holder shall be entitled to indemnification pursuant to this Section 3.9.1 in respect of any untrue statement or omission contained in any information relating
to such seller Holder furnished in writing by such selling Holder to the Company specifically for inclusion in a Registration Statement and used by the Company in conformity therewith (such information “Selling Stockholder
Information”). This indemnity shall be in addition to any liability the Company may otherwise have. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Holder or any indemnified
party and shall survive the Transfer of such securities by such Holder and regardless of any indemnity agreed to in the underwriting agreement that is less favorable to the Holders. 

Section 3.9.2 Indemnification by the Selling Holders. Each selling Holder agrees (severally and not jointly) to indemnify and hold
harmless, to the fullest extent permitted by law, the Company, its directors and officers and each Person who controls the Company (within the meaning of the Securities Act or the Exchange Act) from and against any Losses resulting from (i) any
untrue statement of a material fact in any Registration Statement under which such Registrable Securities were registered or sold under the Securities Act (including any final, preliminary or summary Prospectus contained therein or any amendment
thereof or supplement thereto or any documents incorporated by reference therein) or (ii) any omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus or
preliminary Prospectus, in light of the circumstances under which they were made) not misleading, in each case to the extent, but only to the extent, that such untrue statement or omission is contained in such selling Holder’s Selling
Stockholder Information. In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the proceeds from the sale of its Registrable Securities in the offering giving rise to such indemnification
obligation, net of underwriting discounts and commissions but before expenses, less any amounts paid by such Holder pursuant to Section 3.9.4 and any amounts paid by such Holder as a result of liabilities incurred under the
underwriting agreement, if any, related to such sale. 
 Section 3.9.3 Conduct of Indemnification Proceedings. Any Person
entitled to indemnification hereunder shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that any delay or failure to so notify the indemnifying party shall
relieve the indemnifying party of its obligations hereunder only to the extent, if at all, that it forfeits substantive rights by reason of such delay or failure) and (ii) permit such indemnifying party to assume the defense of such claim with
counsel reasonably satisfactory to the indemnified party; provided, however, that any Person entitled to indemnification hereunder shall have the right to select and employ separate counsel and to participate in the defense of such
claim, but the fees and expenses of such counsel shall be at the expense of such Person unless (i) the indemnifying party has agreed in writing to pay such fees or expenses, (ii) the indemnifying party shall have failed to assume the
defense of such claim within a reasonable time after receipt of notice of such claim from the Person entitled to indemnification hereunder and employ counsel reasonably satisfactory to such Person, (iii) the indemnified party has reasonably
concluded (based 

  
 23 

 
upon advice of its counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party or
(iv) in the reasonable judgment of any such Person (based upon advice of its counsel) a conflict of interest may exist between such Person and the indemnifying party with respect to such claims (in which case, if the Person notifies the
indemnifying party in writing that such Person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of such Person). If the
indemnifying party assumes the defense, the indemnifying party shall not have the right to settle such action without the prior written consent of the indemnified party. If such defense is not assumed by the indemnifying party, the indemnifying
party will not be subject to any liability for any settlement made without its prior written consent, but such consent may not be unreasonably withheld or delayed. Notwithstanding the foregoing, if at any time an indemnified party shall have
requested that an indemnifying party reimburse the indemnified party for reasonable fees and expenses of counsel as contemplated by this paragraph, the indemnifying party shall be liable for any settlement of any proceeding effected without its
written consent if (i) such settlement is entered into in good faith more than 60 days after receipt by the indemnifying party of such request and more than 30 days after receipt of the proposed terms of such settlement and (ii) the
indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement. It is understood that the indemnifying party or parties shall not, except as specifically set forth in this
Section 3.9.3, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements or other charges of more than one separate firm (in addition to any local
counsel) at any one time unless (x) the employment of more than one counsel has been authorized in writing by the indemnifying party or parties, (y) an indemnified party has reasonably concluded (based on the advice of counsel) that there
may be legal defenses available to it that are different from or in addition to those available to the other indemnified parties or (z) a conflict or potential conflict exists or may exist (based upon advice of counsel to an indemnified party)
between such indemnified party and the other indemnified parties, in each of which cases the indemnifying party shall be obligated to pay the reasonable fees and expenses of such additional counsel or counsels. 

Section 3.9.4 Contribution. If for any reason the indemnification provided for in Section 3.9.1 and
Section 3.9.2 is unavailable to an indemnified party (other than as a result of exceptions contained in Section 3.9.1 and Section 3.9.2) or insufficient in respect of any
Losses referred to therein, then the indemnifying party shall contribute to the amount paid or payable by the indemnified party as a result of such Loss in such proportion as is appropriate to reflect the relative fault of the indemnifying party on
the one hand and the indemnified party or parties on the other hand in connection with the acts, statements or omissions that resulted in such Losses, as well as any other relevant equitable considerations. In connection with any Registration
Statement filed with the SEC by the Company, the relative fault of the indemnifying party on the one hand and the indemnified party on the other hand shall be determined by reference to, among other things, whether any untrue or alleged untrue
statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission. The parties hereto agree that it would not be just or equitable if contribution pursuant to this Section 3.9.4 were determined by pro rata allocation or by
any other method of allocation that does not take account of the equitable considerations referred to in this Section 3.9.4. No Person guilty of fraudulent misrepresentation

  
 24 

 
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. The amount paid or
payable by an indemnified party as a result of the Losses referred to in Sections 3.9.1 and 3.9.2 shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably
incurred by such indemnified party in connection with investigating or defending any such action or claim. If indemnification is available under this Section 3.9, the indemnifying parties shall indemnify each indemnified party to the
fullest extent provided in Sections 3.9.1 and 3.9.2 hereof without regard to the provisions of this Section 3.9.4. The remedies provided for in this Section 3.9 are
not exclusive and shall not limit any rights or remedies which may otherwise be available to any indemnified party at law or in equity. Notwithstanding the provisions of this Section 3.9.4, in connection with any
Registration Statement filed by the Company, a selling Holder shall not be required to contribute any amount in excess of the dollar amount of the proceeds from the sale of its Registrable Securities in the offering giving rise to such
indemnification obligation, net of underwriting discounts and commissions but before expenses, less any amounts paid by such Holder pursuant to Section 3.9.2 and any amounts paid by such Holder as a result of liabilities
incurred under the underwriting agreement, if any, related to such sale. 
 Section 3.9.5 Indemnification Priority. The Company
hereby acknowledges and agrees that any of the Persons entitled to indemnification pursuant to Section 3.9.1 (each, a “Company Indemnitee” and collectively, the “Company Indemnitees”) may
have certain rights to indemnification, advancement of expenses and/or insurance provided by other sources. The Company hereby acknowledges and agrees (i) that it is the indemnitor of first resort (i.e., its obligations to a Company Indemnitee
are primary and any obligation of such other sources to advance expenses or to provide indemnification for the same expenses or liabilities incurred by such Company Indemnitee are secondary) and (ii) that it shall be required to advance the
full amount of expenses incurred by a Company Indemnitee and shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement to the extent legally permitted and as required by the terms of this
Agreement without regard to any rights a Company Indemnitee may have against such other sources. The Company further agrees that no advancement or payment by such other sources on behalf of a Company Indemnitee with respect to any claim for which
such Company Indemnitee has sought indemnification, advancement of expenses or insurance from the Company shall affect the foregoing, and that such other sources shall have a right of contribution and/or be subrogated to the extent of such
advancement or payment to all of the rights of recovery of such Company Indemnitee against the Company. 
 Section 3.10 Rules 144
and 144A and Regulation S. The Company shall file the reports required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder (or, if the Company is not required to file such
reports, it will, upon the request of any Holder, make publicly available such necessary information for so long as necessary to permit sales that would otherwise be permitted by this Agreement pursuant to Rule 144, Rule 144A or Regulation S under
the Securities Act, as such rules may be amended from time to time or any similar rule or regulation hereafter adopted by the SEC), and it will take such further action as any Holder may reasonably request, all to the extent required from time to
time to enable such Holder to sell Registrable Securities without Registration under the Securities Act in transactions that would otherwise be permitted by this Agreement and within the limitation of the exemptions provided by (i) Rule 144,
Rule 144A or Regulation S under the Securities Act, as such rules may be amended from time to time, or (ii) any similar rule or regulation hereafter adopted by the SEC. Upon the request of any Holder, the Company will deliver to such Holder a
written statement as to whether it has complied with such requirements and, if not, the specifics thereof. 

  
 25 

 Section 3.11 Existing Registration Statements. Notwithstanding anything herein
to the contrary and subject to applicable law and regulation, the Company may satisfy any obligation hereunder to file a Registration Statement or to have a Registration Statement become effective by a specified date by designating, by notice to the
Holders, a Registration Statement that previously has been filed with the SEC or become effective, as the case may be, as the relevant Registration Statement for purposes of satisfying such obligation, and all references to any such obligation shall
be construed accordingly; provided that such previously filed Registration Statement may be, and is, amended or, subject to applicable securities laws, supplemented to add the number of Registrable Securities, and, to the extent necessary, to
identify as selling stockholders those Holders demanding the filing of a Registration Statement pursuant to the terms of this Agreement. To the extent this Agreement refers to the filing or effectiveness of other Registration Statements, by or at a
specified time and the Company has, in lieu of then filing such Registration Statements or having such Registration Statements become effective, designated a previously filed or effective Registration Statement as the relevant Registration Statement
for such purposes, in accordance with the preceding sentence, such references shall be construed to refer to such designated Registration Statement, as amended or supplemented in the manner contemplated by the immediately preceding sentence. 

ARTICLE IV 
 MISCELLANEOUS 

Section 4.1 Authority; Effect. Each party hereto represents and warrants to and agrees with each other party that the execution
and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized on behalf of such party and do not violate any agreement or other instrument applicable to such party or by which its assets are
bound. This Agreement does not, and shall not be construed to, give rise to the creation of a partnership among any of the parties hereto, or to constitute any of such parties members of a joint venture or other association. The Company and its
subsidiaries shall be jointly and severally liable for all obligations of the Company pursuant to this Agreement. 
 Section 4.2
Notices. Any notices, requests, demands and other communications required or permitted in this Agreement shall be effective if in writing and (i) delivered personally, (ii) sent by e-mail or
(iii) sent by overnight courier, in each case, addressed as follows: 
 if to the Company, to: 

c/o Ensemble Health Partners Holdings, LLC 

4605 Duke Drive 
 Mason, OH
45040 
 Attn: Chief Executive Officer; General Counsel 

E-mail: judson.ivy@ensemblehp.com; van.miller@ensemblehp.com 

  
 26 

 with a copy (which shall not constitute notice) to: 

Ropes & Gray LLP 
 3
Embarcadero Center 
 San Francisco, California 94111 

Attention: Thomas Holden and Eric Issadore 

Facsimile: (415) 315-4823 

E-mail: thomas.holden@ropesgray.com; eric.issadore@ropesgray.com 

If to the GGC Investor, to: 

c/o Golden Gate Capital 
 One
Embarcadero Center 
 San Francisco, CA 

Attn: Rishi Chanda and General Counsel 

E-mail: rchandna@goldengatecap.com; legal@goldengatecap.com 

with a copy (which shall not constitute notice) to: 

Ropes & Gray LLP 
 3
Embarcadero Center 
 San Francisco, California 94111 

Attention: Thomas Holden and Eric Issadore 

Facsimile: (415) 315-4823 

E-mail: thomas.holden@ropesgray.com; eric.issadore@ropesgray.com 

if to the BSMH Investor, to: 

Bon Secours Mercy Health Innovations LLC 

1701 Mercy Health Place 

Cincinnati, OH 45237-6147 

Attn: John M. Starcher, Jr. 

E:mail: JMStarcher@BSMHealth.org 

with a copy (which shall not constitute notice) to: 

Michael A. Bezney 
 1701 Mercy
Health Place 
 Cincinnati, OH 45237-6147 

E-mail: mabezney@BSMHealth.org 

Subject to the foregoing, notice to the holder of record of any Registrable Securities shall be deemed to be notice to the holder of such securities for all
purposes hereof. 
 Unless otherwise specified herein, such notices or other communications shall be deemed effective (i) on the date received, if
personally delivered, (ii) on the date received if delivered by facsimile or e-mail on a Business Day, or if not delivered on a Business Day, on the first Business Day thereafter and (iii) one
Business Day after being sent by overnight courier. Each of the parties hereto shall be entitled to specify a different address by giving notice as aforesaid to each of the other parties hereto. 

  
 27 

 Section 4.3 Termination and Effect of Termination. This Agreement shall
terminate upon the date on which no Holder holds any Registrable Securities, except for the provisions of Sections 3.9 and 3.10, which shall survive any such termination. No termination under this Agreement shall
relieve any Person of liability for breach or Registration Expenses incurred prior to termination. In the event this Agreement is terminated, each Person entitled to indemnification or contribution rights pursuant to
Section 3.9 hereof shall retain such indemnification or contribution rights with respect to any matter that (i) may be a liability subject to indemnification or contribution thereunder and (ii) occurred prior to
such termination. 
 Section 4.4 Permitted Transferees. The rights of a Holder hereunder may be assigned (but only with all
related obligations as set forth below) in connection with a Transfer of Registrable Securities to a Permitted Transferee of that Holder. Without prejudice to any other or similar conditions imposed hereunder with respect to any such Transfer, no
assignment permitted under the terms of this Section 4.4 will be effective unless the Permitted Transferee to which the assignment is being made, if not a Holder, has delivered to the Company a written acknowledgment and
joinder agreement in form and substance reasonably satisfactory to the Company that the Permitted Transferee will be bound by, and will be a party to, this Agreement (such written joinder agreement to include such Permitted Transferee’s contact
information for the delivery of notice). 
 Section 4.5 Remedies. The parties to this Agreement shall have all remedies
available at law, in equity or otherwise in the event of any breach or violation of this Agreement or any default hereunder. The parties acknowledge and agree that in the event of any breach of this Agreement, in addition to any other remedies that
may be available, each of the parties hereto shall be entitled to specific performance of the obligations of the other parties hereto and, in addition, to such other equitable remedies (including preliminary or temporary relief) as may be
appropriate in the circumstances. No delay of or omission in the exercise of any right, power or remedy accruing to any party as a result of any breach or default by any other party under this Agreement shall impair any such right, power or remedy,
nor shall it be construed as a waiver of or acquiescence in any such breach or default, or of any similar breach or default occurring later; nor shall any such delay, omission nor waiver of any single breach or default be deemed a waiver of any
other breach or default occurring before or after that waiver. 
 Section 4.6 Amendments. This Agreement may not be orally
amended, modified, extended or terminated, nor shall any oral waiver of any of its terms be effective. This Agreement may be amended, modified, extended or terminated, and the provisions hereof may be waived, only by an agreement in writing signed
by the Company and each of the Principal Stockholders. In addition, each party hereto may waive any right hereunder by an instrument in writing signed by such party. 

Section 4.7 Governing Law. This Agreement and all claims arising out of or based upon this Agreement or relating to the subject
matter hereof shall be governed by and construed in accordance with the domestic substantive laws of the State of Delaware without giving effect to any choice or conflict of laws provision or rule that would cause the application of the domestic
substantive laws of any other jurisdiction. 

  
 28 

 Section 4.8 Consent to Jurisdiction. Each party to this Agreement, by its
execution hereof, (i) hereby irrevocably submits to the exclusive jurisdiction of the Delaware Court of Chancery within New Castle County in the State of Delaware (or, solely if the Delaware Court of Chancery within New Castle County in the
State of Delaware declines jurisdiction, the Complex Commercial Litigation Division of the Delaware Superior Court, New Castle County, or solely if such court declines jurisdiction, the United States District Court for the District of Delaware) for
the purpose of any action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject matter hereof, (ii) hereby waives to the
extent not prohibited by applicable law, and agrees not to assert, and agrees not to allow any of its Subsidiaries to assert, by way of motion, as a defense or otherwise, in any such action, any claim that it is not subject personally to the
jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that any such proceeding brought in one of the above-named courts is improper, or that this Agreement or the subject matter hereof or thereof
may not be enforced in or by such court and (iii) hereby agrees not to commence or maintain any action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation arising out of or based upon this
Agreement or relating to the subject matter hereof or thereof other than before one of the above-named courts nor to make any motion or take any other action seeking or intending to cause the transfer or removal of any such action, claim, cause of
action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation to any court other than one of the above-named courts whether on the grounds of inconvenient forum or otherwise. Notwithstanding the foregoing, to the extent that
any party hereto is or becomes a party in any litigation in connection with which it may assert indemnification rights set forth in this Agreement, the court in which such litigation is being heard shall be deemed to be included in clause
(i) above. Notwithstanding the foregoing, any party to this Agreement may commence and maintain an action to enforce a judgment of any of the above-named courts in any court of competent jurisdiction. Each party hereto hereby consents to
service of process in any such proceeding in any manner permitted by Delaware law, and agrees that service of process by registered or certified mail, return receipt requested, at its address specified pursuant to
Section 4.2 hereof is reasonably calculated to give actual notice. 
 Section 4.9 WAIVER OF JURY
TRIAL. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW THAT CANNOT BE WAIVED, EACH PARTY HERETO HEREBY WAIVES, AND COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE), ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN
RESPECT OF ANY ISSUE OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE), INQUIRY, PROCEEDING OR INVESTIGATION ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH OR RELATED OR
INCIDENTAL TO THE DEALINGS OF ANY HOLDER IN CONNECTION WITH ANY OF THE ABOVE, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING AND WHETHER IN CONTRACT, TORT OR OTHERWISE. EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE OTHER
PARTIES HERETO THAT THIS SECTION 4.9 CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH IT IS RELYING AND WILL RELY IN ENTERING INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY. ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A
COPY OF THIS SECTION 4.9 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. 

  
 29 

 Section 4.10 Merger; Binding Effect, Etc. This Agreement (along with the
Stockholders Agreement, the Coordination Agreement and the Operating Agreement) constitutes the entire agreement of the parties with respect to its subject matter, supersedes all prior or contemporaneous oral or written agreements or discussions
with respect to such subject matter, and shall be binding upon and inure to the benefit of the parties hereto and thereto and their respective heirs, representatives, successors and permitted assigns. No provision of this Agreement is intended to
confer any rights, benefits, remedies, obligations or liabilities hereunder upon any Person other than the parties hereto and their respective heirs, representatives, successors and permitted assigns other than the Company Indemnitees and Affiliate
Indemnitors under Section 3.9.5 and Ensemble, who is an express third party beneficiary of the restrictions set forth in Section 3.4.2. Except as otherwise expressly provided herein, no Holder or
other party hereto may assign any of its respective rights or delegate any of its respective obligations under this Agreement without the prior written consent of the other parties hereto, and any attempted assignment or delegation in violation of
the foregoing shall be null and void. 
 Section 4.11 Counterparts; Electronic Signatures. This Agreement may be executed in any
number of separate counterparts each of which when so executed shall be deemed to be an original and all of which together shall constitute one and the same agreement. Counterpart signature pages to this Agreement may be delivered by facsimile or
electronic delivery (i.e., by email of a PDF signature page) and each such counterpart signature page will constitute an original for all purposes. The parties hereto hereby agree that this Agreement may be executed by way of electronic signatures
and that the electronic signature has the same binding effect as a physical signature. For the avoidance of doubt, the parties hereto further agree that none of this Agreement nor any provision hereof shall be denied legal effect, validity or
enforceability solely on the grounds that it is in the form of an electronic record. 
 Section 4.12 Severability. In the event
that any provision hereof would, under applicable law, be invalid, illegal or unenforceable in any respect, such provision shall be construed by modifying or limiting it so as to be valid, legal and enforceable to the maximum extent compatible with,
and possible under, applicable law. The provisions hereof, other than Section 4.13 (No Recourse) are severable, and in the event any provision hereof (other than Section 4.13 (No Recourse)) should
be held invalid or unenforceable in any respect, it shall not invalidate, render unenforceable or otherwise affect any other provision hereof. 

Section 4.13 No Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, the Company and each Holder
covenant, agree and acknowledge that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement shall be had against any current or future director, officer, employee, stockholder, general or limited
partner or member of any Holder or of any Affiliate or assignee thereof, as such, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other applicable law, it being
expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any 

  
 30 

 
current or future officer, agent or employee of any Holder or any current or future member of any Holder or any current or future director, officer, employee, stockholder, partner or member of
any Holder or of any Affiliate or assignee thereof, as such, for any obligation of any Holder under this Agreement or any documents or instruments delivered in connection with this Agreement for any claim based on, in respect of or by reason of such
obligations or their creation. 
 [Signature pages follow] 

  
 31 

 IN WITNESS WHEREOF, each of the undersigned has duly executed this Agreement as of the date
first above written. 
  

			
	ENSEMBLE HEALTH PARTNERS, INC.
	
	  
 By:

	Name:	 	
	Title:	 	
	
	EHL ACQUISITION HOLDINGS, LLC

  

			
	  
 By:

	Name:	 	
	Title:	 	

  

			
	BON SECOURS MERCY HEALTH INNOVATIONS LLC
	
	  
 By:

	Name:	 	
	Title:	 	

 [Signature Page to Registration Rights Agreement]EX-10.10

 EXHIBIT 10.10 
  

 
 STOCKHOLDERS AGREEMENT 

BY AND AMONG 
 ENSEMBLE
HEALTH PARTNERS, INC. 
 AND 

THE STOCKHOLDERS PARTY HERETO 

DATED AS OF [    ], 2021 
  

 

 TABLE OF CONTENTS 

 

							
	 	  	Page	 
	 ARTICLE I DEFINITIONS
	  	 	1	 
			
	 Section 1.1.
	 	Definitions	  	 	1	 
			
	 Section 1.2.
	 	Other Terms	  	 	4	 
			
	 Section 1.3.
	 	Other Interpretive Provisions	  	 	5	 
		
	 ARTICLE II REPRESENTATIONS AND WARRANTIES
	  	 	6	 
			
	 Section 2.1.
	 	Existence; Authority; Enforceability	  	 	6	 
			
	 Section 2.2.
	 	Absence of Conflicts	  	 	7	 
			
	 Section 2.3.
	 	Consents	  	 	7	 
		
	 ARTICLE III GOVERNANCE
	  	 	7	 
			
	 Section 3.1.
	 	The Board	  	 	7	 
			
	 Section 3.2.
	 	Voting Agreement	  	 	11	 
			
	 Section 3.3.
	 	Special Approval Matters	  	 	11	 
			
	 Section 3.4.
	 	Books and Records; Access; Notice	  	 	11	 
		
	 ARTICLE IV GENERAL PROVISIONS
	  	 	11	 
			
	 Section 4.1.
	 	Company Charter and Company Bylaws	  	 	11	 
			
	 Section 4.2.
	 	Freedom to Pursue Opportunities	  	 	11	 
			
	 Section 4.3.
	 	Assignment; Benefit	  	 	12	 
			
	 Section 4.4.
	 	Restrictions on Business Combination Transactions	  	 	12	 
			
	 Section 4.5.
	 	Standstill	  	 	12	 
			
	 Section 4.6.
	 	Termination	  	 	13	 
			
	 Section 4.7.
	 	Severability	  	 	13	 
			
	 Section 4.8.
	 	Entire Agreement; Amendment	  	 	13	 
			
	 Section 4.9.
	 	Counterparts; Electronic Signatures	  	 	14	 
			
	 Section 4.10.
	 	Notices	  	 	14	 
			
	 Section 4.11.
	 	Governing Law	  	 	15	 
			
	 Section 4.12.
	 	Consent to Jurisdiction	  	 	15	 
			
	 Section 4.13.
	 	Waiver of Jury Trial	  	 	16	 
			
	 Section 4.14.
	 	Remedies	  	 	16	 
			
	 Section 4.15.
	 	Subsequent Acquisition of Shares	  	 	17	 
			
	 Section 4.16.
	 	Restrictions on Transfer or Issuance of Class B Common Stock	  	 	17	 
			
	 Section 4.17.
	 	No Recourse	  	 	18	 
			
	 Section 4.18.
	 	Effectiveness	  	 	18	 

 Exhibit A – Form of Indemnification Agreement 

 This STOCKHOLDERS AGREEMENT (as it may be amended from time to time in accordance
with the terms hereof, this “Agreement”), dated as of [    ], 2021, is made by and among Ensemble Health Partners, Inc., a Delaware corporation (the “Company”); EHL Acquisition Holdings, LLC, a
Delaware limited liability company (“GGC”); Bon Secours Mercy Health Innovations, LLC, an Ohio limited liability company (“Innovations”); and such other Persons who from time to time become party hereto by executing
a counterpart signature page hereof and are designated by the Board (as defined below) as “Other Stockholders” (the “Other Stockholders” and, together with the BSMH Investor and the GGC Investor, the
“Stockholders”). 
 W I T N E S S E T H: 

WHEREAS, on the date hereof, the Company has priced an initial public offering (the “IPO”) of shares of its Class A
common stock, par value $0.001 per share (the “Class A Common Stock”), pursuant to an Underwriting Agreement dated as of the date hereof; 

WHEREAS, in connection with the IPO (a) the amended and restated limited liability company agreement (the “Operating
Agreement”) of Ensemble Health Partners Holdings, LLC, a Delaware limited liability company (“Ensemble”) will be amended and restated, with the Company becoming Ensemble’s sole managing member and (b) pursuant to
a series of exchanges and contributions, the Company will issue shares of Class A Common Stock and shares of Class B common stock, par value $0.001 per share (the “Class B Common Stock” and, together
with the Class A Common Stock, the “Common Stock”), to certain of Ensemble’s pre-IPO unit holders; 

WHEREAS, after the completion of the IPO, the Common Units of Ensemble (the “LLC Units”), together with shares of
Class B Common Stock will, subject to certain restrictions, be redeemable from time to time at the option of the holder thereof for shares of Class A Common Stock, pursuant to the Operating Agreement; and 

WHEREAS, the parties hereto desire to provide for certain governance rights and other matters, and to set forth the respective rights and
obligations of the Stockholders following the IPO. 
 NOW, THEREFORE, in consideration of the foregoing and the mutual promises, covenants
and agreements of the parties hereto, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows: 

ARTICLE I 
 DEFINITIONS 

Section 1.1. Definitions. As used in this Agreement, the following terms shall have the following meanings: 

“Affiliate” means, with respect to any specified Person, any other Person that directly or indirectly Controls, is under
common Control with or is Controlled by such Person; provided that the Company and each Subsidiary of the Company shall be deemed not to be an Affiliate of any Principal Stockholder, any Person that Controls such Principal Stockholder or any
Person with 

 
whom the Company or any such Subsidiary would otherwise be Affiliated through Affiliation with such Principal Stockholder or any Person that controls such Principal Stockholder. The terms
“Affiliate”, “Affiliated” and “Affiliation” shall have correlative meanings. As used in this definition, the term “control” means the possession, directly or indirectly, of the power to
direct or cause the direction of the management and policies of a Person, whether through ownership of voting securities, by contract or otherwise. 

“Board” means the board of directors of the Company. 

“BSMH” means Bon Secours Mercy Health, Inc., a Maryland nonprofit corporation that is a Code Section 501(c)(3)
charitable organization and is a public charity within the meaning of Code Section 509(a)(1). 
 “BSMH Investor” means
Innovations, together with its Permitted Transferees that hold Company Shares and agree to the provisions of Section 3.2 hereof. 

“Business Combination Transaction” has the meaning set forth in Section 4.4. 

“Business Day” means any day other than a Saturday or Sunday or any other day on which commercial banks are required or
permitted to close by law in the City of New York, New York or City of San Francisco, California. 
 “Chief Executive
Officer” means the chief executive officer of the Company then in office. 
 “Class A Common
Stock” has the meaning set forth in the Recitals. 
 “Class B Common Stock” has the meaning set
forth in the Recitals. 
 “Closing” means the closing of the IPO. 

“Common Stock” has the meaning set forth in the Recitals. 

“Company Bylaws” means the bylaws of the Company in effect on the date hereof, as may be amended from time to time. 

“Company Charter” means the certificate of incorporation of the Company in effect on the date hereof, as may be amended from
time to time. 
 “Company Shares” means (a) all shares of Common Stock that are not then subject to vesting (including
shares that were at one time subject to vesting to the extent they have vested), (b) all shares of Common Stock issuable upon exercise, redemption, conversion or exchange of any option, warrant or convertible or other security that are directly or
indirectly convertible into or exchangeable, redeemable or exercisable for shares of Common Stock and are not then subject to vesting (including options, warrants and convertible or other securities that were at one time subject to vesting to the
extent they have vested) (without double counting shares of Class A Common Stock issuable upon a redemption of shares of Class B Common Stock together with LLC Units) and (c) all shares of Common Stock directly or indirectly issued or
issuable with respect to the securities referred to in clause (a) or (b) above by way of unit or stock dividend or unit or stock split, or in connection with a combination of units or shares, recapitalization, merger, consolidation or other
reorganization. 

  
 2 

 “Coordination Agreement” means that certain Coordination Agreement, dated
on or about the date hereof, by and among the BSMH Investor and the GGC Investor 
 “Exchange Act” means the Securities
Exchange Act of 1934. 
 “GGC” has the meaning set forth in the Preamble. 

“GGC Investor” means, collectively, GGC, together with its Permitted Transferees that hold Company Shares and agrees to the
provisions of Section 3.2 hereof. 
 “Independent Director” means a director of the Company who
qualifies as independent for purposes of serving on the Board under the rules of the Nasdaq Global Market (the “Exchange”). 

“Necessary Action” means, with respect to a specified result, all actions reasonably necessary to cause such result through
the exercise of rights attaching to Common Stock or LLC Units then held by a Stockholder, including (i) voting or providing a written consent or proxy with respect to the Company Shares, including in respect of the adoption of
stockholders’ resolutions and amendments to the organizational documents of the Company, and (ii) executing written consents in respect thereof. 

“Permitted Transferees” means, with respect to any Stockholder, (i) such Persons as each Principal Stockholder then
party to this Agreement approves in writing and (ii) any Affiliate of such Stockholder. 
 “Person” means any
individual, partnership, limited liability company, corporation, trust, association, estate, unincorporated organization or government or any agency or political subdivision thereof. 

“Principal Stockholder” means each of the BSMH Investor and the GGC Investor. 

“Representative” means, with respect to any Person, any director, manager, officer, employee, agent, consultant, advisor, or
other representative of such Person, including legal counsel, accountants, and financial advisors. 
 “SEC” means the U.S.
Securities and Exchange Commission. 
 “Share Exchange” means a share exchange involving more than 50% of the shares of the
Common Stock; provided that a redemption or exchange of Class B Common Stock (together with LLC Units) for Class A Common Stock effected in accordance with Section 9.01 of the Operating Agreement shall not constitute a “Share
Exchange” for purposes of this Agreement. 
 “Subsidiary” means, with respect to any Person, any corporation, limited
liability company, partnership, association or business entity of which (a) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency) to vote in the election of
directors, managers or trustees thereof is at the time owned or controlled, 

  
 3 

 
directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (b) if a limited liability company, partnership, association or
other business entity (other than a corporation), a majority of limited liability company, partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more
Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons shall be deemed to have a majority ownership interest in a limited liability company, partnership, association or other business entity (other than a
corporation) if such Person or Persons shall be allocated a majority of limited liability company, partnership, association or other business entity gains or losses or shall be or control any manager, general partner or board of managers of such
limited liability company, partnership, association or other business entity. For purposes hereof, references to a “Subsidiary” of any Person shall be given effect only at such times that such Person has one or more Subsidiaries.

 “Tax Receivable Agreement” means that certain Tax Receivable Agreement, dated on or about the date hereof, by and among
the Company, Ensemble and the other Persons party thereto, as the same may be amended, restated, supplemented and/or otherwise modified, from time to time. 

“Transaction Documents” means the Registration Rights Agreement, Restructuring Agreement, the Operating Agreement, the
Coordination Agreement and the Tax Receivable Agreement. 
 “Registration Rights Agreement” means that certain Registration
Rights Agreement, dated on or about the date hereof, by and among the Company, each Principal Stockholder and the other Persons party thereto or that may become parties thereto from time to time, as the same may be amended, restated, supplemented
and/or otherwise modified, from time to time. 
 “Restructuring Agreement” means, that certain Master Restructuring
Agreement, dated on or about the date hereof, by and among the Company, Ensemble and other parties thereto, as the same may be amended, restated, supplemented and/or otherwise modified, from time to time. 

“Transfer” means a transfer, sale, assignment, pledge, grant of a security interest in, encumbrance, hypothecation or other
disposition (including the creation of any derivative or synthetic interest, including a participation or other similar interest or any lien or encumbrance), in any case, whether by operation of Law or otherwise, and shall include any transaction
that is treated as a “transfer” within the meaning of Treasury Regulations Section 1.7704-1; and “Transferred,” “Transferee” and “Transferor” shall each have a
correlative meaning. 
 “Transfer Agent” has the meaning set forth in Section 4.17(b). 

Section 1.2. Other Terms. The following terms shall have the meanings specified in the indicated Section of this Agreement. 

 

			
	 Affiliate Indemnitors
	  	3.1(k)
	 BSMH Designee
	  	3.1(c)
	 BSMH Director
	  	3.1(a)
	 BSMH Unaffiliated Director
	  	3.1(a)
	 Business Combination Transaction
	  	4.4

  
 4 

			
	 Class A Common Stock
	  	Recitals
	 Class B Common Stock
	  	Recitals
	 Common Stock
	  	Recitals
	 Company
	  	Preamble
	 Ensemble
	  	Recitals
	 GGC Designee
	  	4.1(b)
	 GGC Director
	  	3.1(a)
	 Indemnification Sources
	  	3.1(k)
	 Indemnitee
	  	3.1(k)
	 Innovations
	  	Preamble
	 Investor Designee
	  	3.1(c)
	 IPO
	  	Recitals
	 LLC Units
	  	Recitals
	 Operating Agreement
	  	Recitals
	 Other Stockholders
	  	Recitals
	 Purported Owner
	  	4.16(b)
	 Restricted Shares
	  	4.16(b)
	 Restrictions
	  	4.16(b)
	 Standstill Period
	  	4.5
	 Stockholder
	  	Preamble
	 Transfer Agent
	  	4.16(b)
	 Unaffiliated Director
	  	3.1(a)

 Section 1.3. Other Interpretive Provisions. 

(a) The definitions in Section 1.1 and elsewhere in this Agreement shall apply equally to both the singular and
plural forms of the terms defined. 
 (b) Whenever the context may require, any pronoun shall include the corresponding masculine, feminine
and neuter forms. 
 (c) Whenever the words “include”, “includes” or “including” are used
in this Agreement, they shall be deemed to be followed by the words “without limitation”, whether or not they are in fact followed by those words or words of like import. 

(d) References to Articles and Sections are to Articles and Sections of this Agreement unless otherwise specified. 

(e) The captions and headings of this Agreement are included for convenience of reference only and shall be ignored in the construction or
interpretation of this Agreement. 
 (f) “Writing”, “written” and comparable terms refer to printing, typing and other
means of reproducing words (including electronic media) in a visible form. 
 (g) The use of the word “or” is not exclusive. 

  
 5 

 (h) Unless otherwise expressly provided herein, any agreement or instrument defined or
referred to herein or in any agreement or instrument that is referred to herein means such agreement or instrument as from time to time amended, modified, supplemented or restated, including by waiver or consent, and references to all attachments
thereto and instruments incorporated therein. 
 (i) References from or through any date mean, unless otherwise specified, from and including
or through and including, respectively. 
 (j) Unless otherwise expressly provided herein, (i) any statute or law defined or referred to
herein means such statute or law as amended, and applicable rules and regulations thereunder, and any successor to such statute, rules or regulations, and any reference herein to a specific section, rule or regulation of such statute or law shall be
deemed to include any corresponding provisions of future law and (ii) any agreement or instrument defined or referred to herein means such agreement as amended, restated, supplemented or otherwise modified from time to time in accordance with
its terms (including by waiver or consent) and applicable law. 
 (k) When any approval consent or other matter requires any action or
approval of the BSMH Investor or the GGC Investor, such approval, consent or other matter shall be deemed given if delivered by the GGC Investor or BSMH Investor, as applicable, holding a majority in interest of all GGC Investors or BSMH Investors,
respectively. 
 (l) Any time that a provision of this Agreement refers to a threshold percentage of ownership of equity securities, such
threshold percentage shall be equitably adjusted for any stock dividend, stock split, reverse stock split, combination of stock, reclassification, recapitalization or similar transaction. 

ARTICLE II 
 REPRESENTATIONS AND
WARRANTIES 
 Each of the parties to this Agreement hereby represents and warrants, severally and not jointly (and solely as to itself), to
each other party to this Agreement that as of the date such party executes this Agreement: 
 Section 2.1. Existence; Authority;
Enforceability. Such party has the necessary power and authority to enter into this Agreement and to perform its obligations hereunder. Such party is duly organized and validly existing under the laws of its jurisdiction of organization, and the
execution of this Agreement, and the performance of its obligations hereunder, have been authorized by all necessary action on the part of its board of directors (or equivalent) and shareholders (or other holders of equity interests), if required,
and no other act or proceeding on its part is necessary to authorize the execution of this Agreement or the performance of its obligations hereunder. This Agreement has been duly executed by such party and constitutes its legal, valid and binding
obligation, enforceable against it in accordance with its terms, subject to the effect of any laws relating to bankruptcy, reorganization, insolvency, moratorium, fraudulent conveyance or preferential transfers, or similar laws relating to or
affecting creditors’ rights generally and subject, as to enforceability, to the effect of general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). 

  
 6 

 Section 2.2. Absence of Conflicts. The execution and delivery by such party of
this Agreement and the performance of its obligations hereunder does not and will not (a) conflict with, or result in the breach of, any provision of the constitutive documents of such party, (b) result in any material violation, breach,
conflict, default or an event of default (or an event which with notice, lapse of time, or both, would constitute a default or an event of default), or give rise to any right of acceleration or termination or any additional material payment
obligation, under the terms of any material contract, agreement or permit to which such party is a party or by which such party’s assets or operations are bound or affected, or (c) violate any law applicable to such party, except, in the
case of each of (b) and (c) with respect to the Stockholders, for any such violation, breach, conflict or default that would not impair in any material respect the ability of such Stockholder to perform its respective obligations hereunder.

 Section 2.3. Consents. Other than as expressly required herein or any consents which have already been obtained, no material
consent, waiver, approval, authorization, exemption, registration, license, permit or declaration is required to be made or obtained by such party in connection with the execution, delivery or performance of this Agreement by such party. 

ARTICLE III 
 GOVERNANCE 

Section 3.1. The Board. 

(a) Composition of Initial Board. The Company and the Principal Stockholders shall take all Necessary Action within their control to
cause, prior to the first annual meeting of the Company’s stockholders, the Board to be comprised of nine (9) directors, (i) one of which will be the then current CEO of the Company; (ii) two of whom shall be individuals jointly
designated by the BSMH Investor and the GGC Investor, each of whom must qualify as an Independent Director and eligible to serve as a member of the Audit Committee (the “Unaffiliated Directors”), (iii) three of whom shall be
designated by the GGC Investor (each, a “GGC Director”) and (iv) three of whom shall be designated by the BSMH Investor (the “BSMH Director”), at least one of whom must be an Independent Director and eligible
to serve as a member of the Audit Committee (the “BSMH Unaffiliated Director”). The foregoing directors shall be divided into three (3) classes of directors, each of whose members shall serve for staggered three-year terms as
follows: 
  

	 	(1)	 the class I directors shall include one (1) GGC Director, one (1) BSMH Director who shall be the BSMH
Unaffiliated Director and one (1) Unaffiliated Director; 

  

	 	(2)	 the class II directors shall include one (1) GGC Director, one (1) Unaffiliated Director and one
(1) BSMH Director; and 

  

	 	(3)	 the class III directors shall include the Chief Executive Officer, one (1) BSMH Director and one
(1) GGC Director. 

  
 7 

 The initial term of the class I directors shall expire immediately following the Company’s first annual
meeting of stockholders at which directors are elected following the completion of the IPO. The initial term of the class II directors shall expire immediately following the Company’s second annual meeting of stockholders at which directors are
elected following the completion of the IPO. The initial term of the class III directors shall expire immediately following the Company’s third annual meeting at which directors are elected following the completion of the IPO. 

(b) GGC Representation. For so long as the GGC Investor holds a number of shares of Common Stock representing at least the percentage of
shares of Common Stock held by the GGC Investor as of the Closing (after giving effect to any exercise by the underwriters of their option to purchase additional shares as well as the repurchase of Class B Common Stock and LLC Units by the
Company, if any, in connection with the closing of the IPO) shown below, there shall be included in the slate of nominees recommended by the Board for election as directors at each applicable annual or special meeting of stockholders at which
directors are to be elected that number of individuals designated by the GGC Investor (each, a “GGC Designee”) that, if elected, will result in the number of GGC Designees serving as directors on the Board that is shown below. 

 

					
	 Ownership Percentage of Shares of Common stock held as of the
Closing
	  	Number of GGC Designees	 
	 45% or greater
	  	 	3	 
	 Less than 45% but greater than or equal to 15%
	  	 	2	 
	 Less than 15% but greater than 5%
	  	 	1	 

 (c) BSMH Representation. For so long as the BSMH Investor holds a number of shares of Common Stock
representing at least the percentage of the number of shares of Common Stock held by the BSMH Investor as of the Closing (after giving effect to any exercise by the underwriters of their option to purchase additional shares as well as the repurchase
of Class B Common Stock and LLC Units by the Company, if any, in connection with the closing of the IPO) shown below, there shall be included in the slate of nominees recommended by the Board for election as directors at each applicable annual
or special meeting of stockholders at which directors are to be elected that number of individuals designated by the BSMH Investor (each, a “BSMH Designee” and any of the BSMH Designee or the GGC Designee, an “Investor
Designee”) that, if elected, will result in the number of BSMH Designees serving as directors on the Board that is shown below, at least one of whom must be (i) an Independent Director for so long as the BSMH Investor has the right to
three BSMH Designees and (ii) eligible to serve as a member of the Audit Committee for so long as there are not three other directors eligible to serve as a member of the Audit Committee. 

 

					
	 Ownership Percentage of Shares of Common stock held as of the
Closing
	  	Number of BSMH Designees	 
	 45% or greater
	  	 
	3 (at least one of whom must
be an Independent Director)	 
 
	 Less than 45% but greater than or equal to 15%
	  	 	2	 
	 Less than 15% but greater than or equal to 5%
	  	 	1	 

  
 8 

 (d) Offer to Tender Resignation. Once any Principal Stockholder no longer has the
right to designate a director for election to the Board as described in Section 3.1(b) or (c), such Principal Stockholder shall take all Necessary Action within its control to cause the appropriate number of such
Principal Stockholder’s designees to tender his or her resignation from the Board effective at the Company’s next annual meeting of stockholders. The Board shall have the option, but not the obligation, to accept or reject any such
resignation. The Company by approval of the Board shall fill any resulting vacancy with a director who qualifies as independent for purposes of serving on the Board under the rules of the Exchange and who is not affiliated with the BSMH Investor or
the GGC Investor. 
 (e) CEO Representation. Subject to the second to last sentence of Section 3.1(f), if
the term of the Chief Executive Officer as a director on the Board is to expire in conjunction with any annual or special meeting of stockholders at which directors are to be elected, the Chief Executive Officer shall be included in the slate of
nominees recommended by the Board for election. 
 (f) Vacancies. Each Principal Stockholder shall have the exclusive right to
designate for election or appointment to the Board directors to fill any vacancy created by reason of death, removal, disability, retirement or resignation of its designees to the Board, and the Company and the other Stockholders shall take all
Necessary Action within their control to cause any such vacancy to be filled by replacement directors designated by such designating Principal Stockholder as promptly as reasonably practicable; provided, that, for the avoidance of doubt and
notwithstanding anything to the contrary in this paragraph, no Principal Stockholder shall have the right to designate a replacement director, and the Company and the other Stockholders shall not be required to take any action to cause any vacancy
to be filled by any such designee, to the extent that election or appointment of such designee to the Board would result in a number of directors designated by such Principal Stockholder in excess of the number of directors that such Principal
Stockholder is then entitled to designate for membership on the Board pursuant to Section 3.1(b) or (c). If the Chief Executive Officer resigns or is terminated for any reason, the Chief Executive Officer shall
resign from the Board, and the Company and the Stockholders shall take all Necessary Action within their control to remove the Chief Executive Officer from the Board and fill such vacancy with the next Chief Executive Officer in office. Each of the
GGC Designee(s) and the BSMH Designee(s) may only be removed (i) for cause by the affirmative vote of the holder of at least sixty-six and two-thirds of the voting
power of the outstanding shares of common stock of the Company or (ii) by, as applicable, the GGC Investor or the BSMH Investor; provided, however, any GGC Designee(s) or BSMH Designee(s) removed pursuant to clause (ii) may only be
replaced by the GGC Investor or BSMH Investor, respectively. 
 (g) Additional Unaffiliated Directors. For so long as any Principal
Stockholder has the right to at least one (1) Investor Designee, the Company will take all Necessary Action within its control to ensure that the number of directors serving on the Board shall not exceed nine (9); provided, that
(A) the number of directors may be increased if necessary to satisfy the requirements of applicable laws and stock exchange regulations and applicable listing requirements and (B) the number of directors serving on the Board may be
increased with the prior written consent of each Principal Stockholder that has the right to designate at least one (1) director for nomination under this Agreement. 

  
 9 

 (h) Committees. Subject to applicable laws and stock exchange regulations, for so
long as a Principal Stockholder has the right to designate at least one (1) director for nomination under this Agreement, such Principal Stockholder shall have the right to have one of its designees serving on the Board (if any) appointed to
serve on each committee of the Board, other than (i) the Audit Committee of the Board and (ii) in the case of the BSMH Investor, any committee established to address matters in which BSMH has a conflict of interest. At all times during
which this Agreement is operative and effective, the Board shall have determined that at least one (1) director serving on the Audit Committee of the Board shall qualify as an “audit committee financial expert” under the rules and
regulations of the SEC. 
 (i) Reimbursement and Indemnification. In accordance with the Company Bylaws, each of the directors will be
entitled to reimbursement of expenses (including travel, lodging and meal expenses) in connection with their attendance and participation in meetings of the Board, the boards of directors and equivalent governing bodies of Ensemble and each of the
Company’s and Ensemble’s Subsidiaries and any committees thereof. In addition, each (x) Unaffiliated Director, BSMH Unaffiliated Director, Investor Designee that is an Independent Director, and (y), subject to the consent of each
Principal Stockholder, each other Investor Designee, GGC Director and BSMH Director shall, in the case of each of (x) and (y), be entitled to such compensation as may be approved by the Board. 

(j) D&O Insurance; Indemnification Priority. The Company shall obtain customary director and officer indemnity insurance on
reasonable terms, which insurance shall cover each director and the members of each board of directors (or equivalent governing body) of the Company, Ensemble and each of their respective Subsidiaries. The Company hereby acknowledges that any
director, officer or other indemnified person covered by (w) any such indemnity insurance policy, (x) the certificate of incorporation and bylaws of the Company, (y) the organizational documents of any subsidiary of the Company and
(z) any other agreement between such director, officer or other indemnified person on the one hand, and the Company or any of its Subsidiaries on the other (the sources of indemnification described in clauses (w), (x), (y) and (z), the
“Indemnification Sources” and any such indemnified person, an “Indemnitee”) may have certain rights to indemnification, advancement of expenses and/or insurance provided by the Stockholders or one or more of their
respective Affiliates (other than the Company and its Subsidiaries) (collectively, the “Affiliate Indemnitors”). The Company hereby agrees that (i) as between the Indemnification Sources, on the one hand, and the Affiliate
Indemnitors, on the other hand, the Indemnification Sources shall be fully and primarily responsible for any claim indemnifiable by the Indemnification Sources, regardless of the availability of recovery from any Affiliate Indemnitor, and the
obligations of any Affiliate Indemnitor with respect to any such claim shall be secondary, and (ii) the Company irrevocably waives, relinquishes and releases and shall cause the other Indemnification Sources to irrevocably waive, relinquish and
release the Affiliate Indemnitors from any and all claims against the Affiliate Indemnitors for contribution, subrogation or any other recovery of any kind in respect thereof. The Company further agrees that no advancement or payment by the
Affiliate Indemnitors with respect to any claim for which an Indemnitee has sought indemnification from the Indemnification Sources shall affect the foregoing and the Affiliate Indemnitors shall be subrogated to the extent of such advancement or
payment to all of the rights of recovery of such Indemnitee against the Indemnification Sources. The Company agrees to indemnify the Affiliate Indemnitors directly for any amounts that the Affiliate Indemnitors pay as indemnification or advancement
on behalf of any indemnified person for which such indemnified person is entitled to indemnification or advancement from the Indemnification Sources. The Company will additionally enter into supplementary indemnification agreements with each of its
directors, in the form attached hereto as Exhibit A. 

  
 10 

 Section 3.2. Voting Agreement. Each Stockholder shall cast all votes to which
such Stockholder is entitled in respect of such Stockholder’s Company Shares, whether at any annual or special meeting, by written consent or otherwise, so as to cause to be elected to the Board those individuals as have been designated in
accordance with Section 3.1(a)-(g) and to otherwise effect the intent of this Article III. 

Section 3.3. Special Approval Matters. For so long as a Principal Stockholder owns greater than or equal to 25% of the Common
Stock owned by it at the Closing (after giving effect to any exercise by the underwriters of their option to purchase additional shares as well as the repurchase of Class B Common Stock and LLC Units by the Company, if any, in connection with
the closing of the IPO), the following matters will require the approval of such Principal Stockholder: 
 (a) the liquidation, dissolution
or winding up of affairs of the business of the Company; or 
 (b) the hiring or termination of the Company’s chief executive officer
(other than in the case of a termination for “cause” or “due cause” as such term (or equivalent term) is defined in any written employment or severance agreement between the Company, Ensemble or any of their respective
Subsidiaries and the chief executive officer). 
 Section 3.4. Books and Records; Access; Notice. For so long as a Principal
Stockholder has the right to at least one (1) Investor Designee, the Company shall provide such Principal Stockholder and its designated representatives (that, for the avoidance of doubt, cannot include any prospective Transferee (other than
Permitted Transferee) or customer of the Company (other than, in the case of the BSMH Investor, BSMH and its controlled Affiliates)), at reasonable times and upon reasonable prior notice to the Company, to review the books and records of the Company
and its Subsidiaries and to discuss the affairs, finances and condition of the Company or any of its Subsidiaries with the officers of the Company. 

ARTICLE IV 
 GENERAL PROVISIONS

 Section 4.1. Company Charter and Company Bylaws. The provisions of this Agreement shall be controlling if any such provisions
or the operation thereof conflict with the provisions of the Company Charter or the Company Bylaws. The Company and the Stockholders agree to take all Necessary Action within their control to amend the Company Charter and Company Bylaws so as to
avoid any conflict with the provisions hereof. 
 Section 4.2. Freedom to Pursue Opportunities. The Company agrees that, without
the consent of the GGC Investor and the BSMH Investor, it shall not take any action, or adopt any resolution, inconsistent with Article IX of the Company Charter. 

  
 11 

 Section 4.3. Assignment; Benefit. 

(a) The rights and obligations hereunder shall not be assignable without the prior written consent of the other parties hereto, subject to the
prior termination of this Agreement with respect to any Stockholder in accordance with Section 4.5; provided that each of the parties to this Agreement may assign its rights and obligations hereunder to Permitted
Transferees that are Affiliates without the prior written consent of the other parties hereto. Any attempted assignment of rights or obligations in violation of this Section 4.3 shall be null and void. 

(b) This Agreement shall be binding upon and shall inure to the benefit of the parties hereto, and their respective successors and permitted
assigns, and there shall be no third-party beneficiaries to this Agreement other than the Indemnitees and the Affiliate Indemnitors under Section 3.1(h), and Exempted Persons (as defined in the Company Charter) under
Section 4.2. 
 Section 4.4. Restrictions on Business Combination Transactions. The Company shall not
be a party to any reorganization, Share Exchange, consolidation, conversion or merger or any other transaction having an effect on stockholders substantially similar to that resulting from a reorganization, Share Exchange, consolidation, conversion
or merger (each a “Business Combination Transaction”) that includes or is in conjunction with a transaction involving the disposition, exchange or conversion of LLC Units for consideration unless (a) each holder of Class A
Common Stock and Class B Common Stock (together with the corresponding number of LLC Units) is allowed to participate pro rata in such Business Combination Transaction (as if the Class B Common Stock (together with the corresponding number
of LLC Units) had been exchanged immediately prior to such Business Combination Transaction for Class A Common Stock pursuant to the Operating Agreement) and (b) the gross proceeds payable in respect of each LLC Unit equals the gross
proceeds that would be payable on account of such LLC Unit if it were exchanged immediately prior to such Business Combination Transaction into Class A Common Stock pursuant to the Operating Agreement. Nothing in this
Section 4.4 shall modify any of the rights set forth in the Tax Receivable Agreement. 
 Section 4.5.
Standstill. Each of the GGC Investor and the BSMH Investor agrees that, notwithstanding Section 4.6 hereof, until the later of (a) the date that is two (2) years following the Closing and (b) the date
that the GGC Investor loses its right to designate a director pursuant to Section 3.1(b), in the case of the GGC Investor, or the date that the BSMH Investor loses its right to designate a director pursuant to
Section 3.1(c), in the case of BSMH Investor (the “Standstill Period”), neither such Stockholder nor its Affiliates or Representatives (acting on its behalf or on behalf of such Stockholder or any of its
Affiliates or at its direction or the direction of such Stockholder or any of its Affiliates will, directly or indirectly, without the prior written consent of the Board or as expressly permitted herein, (i) acquire, agree to acquire, propose,
seek or offer to acquire, or knowingly facilitate the acquisition or ownership of, any securities or indebtedness of the Company, any warrant or option to purchase such securities or indebtedness, any security convertible into any such securities or
indebtedness (other than, for the avoidance of doubt, the issuance of shares of Class A Common Stock upon an exchange of shares of Class B Common Stock together with LLC Units), or any other right to acquire such securities or indebtedness
that would result in such Stockholder owning more than forty-nine percent (49%) of the outstanding voting power of the Company or (ii) enter, agree to enter, propose, seek or offer to enter into or

  
 12 

 
knowingly facilitate any merger, business combination, recapitalization, restructuring or other extraordinary transaction involving the Company on the one hand and any Principal Stockholder or
one or more of their Affiliates on the other hand. Notwithstanding the foregoing, each of the GGC Investor and the BSMH Investor shall be entitled to have discussions with the Chief Executive Officer of the Company and the Chairperson of the Board
of the Company (if any), or the full Board (or any committee thereof), regarding any of the matters set forth in this Section 4.5, but only so long as such request or proposal does not require public disclosure by the
Company or any such Person. This Section 4.5 shall be of no further force and effect upon the occurrence of any of the following events: (i) the Company enters into a definitive agreement with a person or
“group” of persons involving the direct or indirect acquisition of all or a majority of the Company’s equity securities or all or substantially all of the Company’s assets or (ii) any person (other than the Company, Ensemble
or their respective Subsidiaries or a Principal Stockholder or its Permitted Transferees with respect to such Principal Stockholder) commences a tender offer or exchange offer with respect to securities representing a majority of the voting power of
the Company and the Board fails to recommend against such tender offer or exchange offer within ten (10) Business Days of the commencement thereof. Nothing in this Section 4.5 shall restrict any Stockholder’s
ability to monetize its equity investment in the Company in compliance with applicable securities laws. 
 Section 4.6.
Termination. If not otherwise stipulated, this Agreement shall terminate automatically (without any action by any party hereto) as to each Stockholder as of the latest of (i) the time that such Stockholder no longer has the right to any
Investor Designees and (ii) the date that is the second anniversary of the Closing; provided, that each Stockholder will remain bound by the restrictions on Transfer of Class B Common Stock as set forth in
Section 4.16 herein until the time that such Stockholder no longer owns any shares of Class B Common Stock. 

Section 4.7. Severability. In the event that any provision hereof would, under applicable law, be invalid, illegal or
unenforceable in any respect, such provision shall be construed by modifying or limiting it so as to be valid, legal and enforceable to the maximum extent compatible with, and possible under, applicable law. The provisions hereof, other than
Section 4.17 (No Recourse) are severable, and in the event any provision hereof (other than Section 4.17 (No Recourse)) should be held invalid or unenforceable in any respect, it shall not
invalidate, render unenforceable or otherwise affect any other provision hereof. 
 Section 4.8. Entire Agreement; Amendment.

 (a) This Agreement and the Transaction Documents set forth the entire understanding and agreement among the parties with respect to the
transactions contemplated herein and supersedes and replaces any prior understanding, agreement or statement of intent, in each case written or oral, of any kind and every nature with respect hereto and thereto. 

(b) This Agreement or any provision hereof may only be amended, modified or waived, in whole or in part, at any time by an instrument in
writing signed by each of the Company, the GGC Investor and the BSMH Investor, in each case, for so long as it is a party to this Agreement. 

  
 13 

 (c) No waiver of any provision or default under, nor consent to any exception to, the terms
of this Agreement or any agreement contemplated hereby shall be effective unless in writing and signed and delivered by the party to be bound and then only to the specific purpose, extent and instance so provided. The waiver by any party hereto of a
breach of any provision of this Agreement shall not operate or be construed as a further or continuing waiver of such breach or as a waiver of any other or subsequent breach. Except as otherwise expressly provided herein, no failure on the part of
any party to exercise, and no delay in exercising, any right, power or remedy hereunder, or otherwise available in respect hereof at law or in equity, shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power
or remedy by such party preclude any other or further exercise thereof or the exercise of any other right, power or remedy. 

Section 4.9. Counterparts; Electronic Signatures. This Agreement may be executed in any number of separate counterparts each of
which when so executed shall be deemed to be an original and all of which together shall constitute one and the same agreement. Counterpart signature pages to this Agreement may be delivered by facsimile or electronic delivery (i.e., by email of a
PDF signature page) and each such counterpart signature page will constitute an original for all purposes. The parties hereto hereby agree that this Agreement may be executed by way of electronic signatures and that the electronic signature has the
same binding effect as a physical signature. For the avoidance of doubt, the parties hereto further agree that none of this Agreement nor any provision hereof shall be denied legal effect, validity or enforceability solely on the grounds that it is
in the form of an electronic record. 
 Section 4.10. Notices. Any notices, requests, demands and other communications required
or permitted in this Agreement shall be effective if in writing and (i) delivered personally, (ii) sent by e-mail or (iii) sent by overnight courier, in each case, addressed as follows: 

if to the Company, to: 
 c/o
Ensemble Health Partners Holdings, LLC 
 4605 Duke Drive 

Mason, OH 45040 
 Attn: Chief
Executive Officer; General Counsel 
 E-mail: judson.ivy@ensemblehp.com; van.miller@ensemblehp.com

 with copies (which shall not constitute notice) to: 

Ropes & Gray LLP 
 3
Embarcadero Center 
 San Francisco, California 94111 

Attention: Thomas Holden and Eric Issadore 

E-mail: thomas.holden@ropesgray.com; eric.issadore@ropesgray.com 

if to the GGC Investor, to: 

Golden Gate Capital 
 One
Embarcadero Center 
 San Francisco, CA 

Attn: Rishi Chanda and General Counsel 

E-mail: rchandna@goldengatecap.com; legal@goldengatecap.com 

  
 14 

 with a copy (which shall not constitute notice) to: 

Ropes & Gray LLP 
 3
Embarcadero Center 
 San Francisco, California 94111 

Attention: Thomas Holden and Eric Issadore 

E-mail: thomas.holden@ropesgray.com; eric.issadore@ropesgray.com 

if to the BSMH Investor, to: 

Bon Secours Mercy Health Innovations LLC 

1701 Mercy Health Place 

Cincinnati, OH    45237-6147 

Attn: John M. Starcher, Jr. 
 E-mail: JMStarcher@BSMHealth.org 
 with a copy (which shall not constitute notice) to: 

Michael A. Bezney 
 1701 Mercy
Health Place 
 Cincinnati, OH    45237-6147 

E-mail: mabezney@BSMHealth.org 

Unless otherwise specified herein, such notices or other communications shall be deemed effective (i) on the date received, if personally delivered,
(ii) on the date received if delivered by facsimile or e-mail on a Business Day, or if not delivered on a Business Day, on the first Business Day thereafter and (iii) one (1) Business Day after being
sent by overnight courier. Each of the parties hereto shall be entitled to specify a different address by giving notice as aforesaid to each of the other parties hereto. 

Section 4.11. Governing Law. This Agreement and all claims arising out of or based upon this Agreement or relating to the subject
matter hereof shall be governed by and construed in accordance with the domestic substantive laws of the State of Delaware without giving effect to any choice or conflict of laws provision or rule that would cause the application of the domestic
substantive laws of any other jurisdiction. 
 Section 4.12. Consent to Jurisdiction. Each party to this Agreement, by its
execution hereof, (i) hereby irrevocably submits to the exclusive jurisdiction of the Delaware Court of Chancery within New Castle County in the State of Delaware (or, solely if the Delaware Court of Chancery within New Castle County in the
State of Delaware declines jurisdiction, the Complex Commercial Litigation Division of the Delaware Superior Court, New Castle County, or solely if such court declines jurisdiction, the United States District Court for the District of Delaware) for
the purpose of any action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject

  
 15 

 
matter hereof, (ii) hereby waives to the extent not prohibited by applicable law, and agrees not to assert, and agrees not to allow any of its Subsidiaries to assert, by way of motion, as a
defense or otherwise, in any such action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that any such proceeding brought in one of the
above-named courts is improper, or that this Agreement or the subject matter hereof or thereof may not be enforced in or by such court and (iii) hereby agrees not to commence or maintain any action, claim, cause of action or suit (in contract,
tort or otherwise), inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject matter hereof or thereof other than before one of the above-named courts nor to make any motion or take any other action
seeking or intending to cause the transfer or removal of any such action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation to any court other than one of the above-named courts whether on the
grounds of inconvenient forum or otherwise. Notwithstanding the foregoing, to the extent that any party hereto is or becomes a party in any litigation in connection with which it may assert indemnification rights set forth in this Agreement, the
court in which such litigation is being heard shall be deemed to be included in clause (i) above. Notwithstanding the foregoing, any party to this Agreement may commence and maintain an action to enforce a judgment of any of the above-named
courts in any court of competent jurisdiction. Each party hereto hereby consents to service of process in any such proceeding in any manner permitted by Delaware law, and agrees that service of process by registered or certified mail, return receipt
requested, at its address specified pursuant to Section 4.12 hereof is reasonably calculated to give actual notice. 

Section 4.13. Waiver of Jury Trial. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW THAT CANNOT BE WAIVED, EACH PARTY HERETO HEREBY
WAIVES, AND COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE), ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE), INQUIRY,
PROCEEDING OR INVESTIGATION ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF ANY STOCKHOLDER IN CONNECTION WITH ANY OF THE ABOVE, IN EACH CASE WHETHER
NOW EXISTING OR HEREAFTER ARISING AND WHETHER IN CONTRACT, TORT OR OTHERWISE. EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE OTHER PARTIES HERETO THAT THIS SECTION 4.13 CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH IT IS
RELYING AND WILL RELY IN ENTERING INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY. ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 4.13 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH
PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. 
 Section 4.14. Remedies. The parties to this Agreement shall have all
remedies available at law, in equity or otherwise in the event of any breach or violation of this Agreement or any default hereunder. The parties acknowledge and agree that in the event of any breach of this Agreement, in addition to any other
remedies that may be available, each of the parties hereto shall be entitled to specific performance of the obligations of the other parties hereto and, in addition, to such other equitable remedies (including preliminary or temporary relief) as may
be appropriate 

  
 16 

 
in the circumstances. No delay of or omission in the exercise of any right, power or remedy accruing to any party as a result of any breach or default by any other party under this Agreement
shall impair any such right, power or remedy, nor shall it be construed as a waiver of or acquiescence in any such breach or default, or of any similar breach or default occurring later; nor shall any such delay, omission nor waiver of any single
breach or default be deemed a waiver of any other breach or default occurring before or after that waiver. 
 Section 4.15.
Subsequent Acquisition of Shares. Any equity securities of the Company acquired subsequent to the date hereof by a Stockholder shall be subject to the terms and conditions of this Agreement. 

Section 4.16. Restrictions on Transfer or Issuance of Class B Common Stock. 

(a) No shares of Class B Common Stock may be Transferred or issued unless a corresponding number of LLC Units are Transferred or issued
therewith (including any transfers or issuances of shares of Class B Common Stock held in treasury or otherwise by the Company or any of its subsidiaries) in accordance with the provisions of the Operating Agreement and that the Company will
not register any Transfers of shares of Class B Common Stock that do not satisfy this Section 4.16(a). 
 (b)
Any purported transfer of shares of Class B Common Stock in violation of the restrictions described in Section 4.16(a) (the “Restrictions”) shall be null and void. If, notwithstanding the foregoing
prohibition, a person shall, voluntarily or involuntarily, purportedly become or attempt to become, the purported owner (“Purported Owner”) of shares of Class B Common Stock in violation of the Restrictions, then the Purported
Owner shall not obtain any rights in and to such shares of Class B Common Stock (the “Restricted Shares”), and the purported transfer of the Restricted Shares to the Purported Owner shall not be recognized by the Company’s
transfer agent (the “Transfer Agent”). 
 (c) Upon a determination by the Board that a person has attempted or may attempt
to transfer or to acquire Restricted Shares in violation of Section 4.16(a), the Board may take such action as it deems advisable to refuse to give effect to such transfer or acquisition on the books and records of the
Company, including without limitation to cause the Transfer Agent to record the Purported Owner’s transferor as the record owner of the Restricted Shares, and to institute proceedings to enjoin or rescind any such transfer or acquisition. 

(d) The Board may, to the extent permitted by law, from time to time establish, modify, amend or rescind, by Company Bylaws or otherwise,
regulations and procedures not inconsistent with the provisions of this Section 4.16 for determining whether any acquisition of shares of Class B Common Stock would violate the Restrictions and for the orderly
application, administration and implementation of the provisions of this Section 4.16. Any such procedures and regulations shall be kept on file with the Secretary of the Company and with its Transfer Agent and shall be
made available for inspection by any prospective transferee and, upon written request, shall be provided to any holder of shares of Class B Common Stock. 

  
 17 

 (e) The Board shall have all powers necessary to implement the Restrictions, including
without limitation the power to prohibit the transfer of any shares of Class B Common Stock in violation thereof. 
 Section 4.17.
No Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, the Company and each Stockholder covenant, agree and acknowledge that no recourse under this Agreement or any documents or instruments delivered in
connection with this Agreement shall be had against any current or future director, officer, employee, stockholder, general or limited partner or member of any Stockholder or of any Affiliate or assignee thereof, as such, whether by the enforcement
of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise
be incurred by any current or future officer, agent or employee of any Stockholder or any current or future member of any Stockholder or any current or future director, officer, employee, stockholder, partner or member of any Stockholder or of any
Affiliate or assignee thereof, as such, for any obligation of any Stockholder under this Agreement or any documents or instruments delivered in connection with this Agreement for any claim based on, in respect of or by reason of such obligations or
their creation. 
 Section 4.18. Effectiveness. This Agreement shall become effective upon the execution of the underwriting
agreement in respect of the IPO. 
 [Signature pages follow] 

  
 18 

 IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the day and year
first above written. 
  

	
	ENSEMBLE HEALTH PARTNERS, INC.
	
	
                     
            

	By:
	Name:
	Title:
	
	EHL ACQUISITION HOLDINGS, LLC
	
	  

	By:
	Name:
	Title:
	
	BON SECOURS MERCY HEALTH INNOVATIONS LLC
	
	  

	By:
	Name:
	Title:

 Exhibit A

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00334-of-00352.parquet"}]]